Landmarks in prostate cancer

The field of prostate cancer has been the subject of extensive research that has resulted in important discoveries and shaped our appreciation of this disease and its management. Advances in our understanding of the epidemiology, natural history, anatomy, detection, diagnosis, grading, staging, imag...

Full description

Saved in:
Bibliographic Details
Published inNature reviews. Urology Vol. 15; no. 10; pp. 627 - 642
Main Authors Sathianathen, Niranjan J., Konety, Badrinath R., Crook, Juanita, Saad, Fred, Lawrentschuk, Nathan
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.10.2018
Nature Publishing Group
Subjects
692/308/409
692/699/67/2322
692/699/67/589/466
692/700
Cancer surgery
Care and treatment
Development and progression
Evaluation
Health status indicators
Medicine
Medicine & Public Health
Perspective
Prognosis
Prostate cancer
Urological surgery
Urology
United States
Online AccessGet full text

Cover

Abstract The field of prostate cancer has been the subject of extensive research that has resulted in important discoveries and shaped our appreciation of this disease and its management. Advances in our understanding of the epidemiology, natural history, anatomy, detection, diagnosis, grading, staging, imaging, and management of prostate cancer have changed clinical practice and influenced guideline recommendations. The development of the Gleason score and subsequent modifications enabled accurate prediction of prognosis. Increased anatomical understanding and improved surgical techniques resulted in the development of nerve-sparing surgery for radical prostatectomy. The advent of active surveillance has changed the management of low-risk disease, and chemotherapy and hormonal therapy have improved the outcomes of patients with distant disease. Ongoing research and clinical trials are expected to yield more practice-changing results in the near future. In this Timeline article, the authors discuss studies that have improved our understanding of prostate cancer and influenced management of this disease.
AbstractList The field of prostate cancer has been the subject of extensive research that has resulted in important discoveries and shaped our appreciation of this disease and its management. Advances in our understanding of the epidemiology, natural history, anatomy, detection, diagnosis, grading, staging, imaging, and management of prostate cancer have changed clinical practice and influenced guideline recommendations. The development of the Gleason score and subsequent modifications enabled accurate prediction of prognosis. Increased anatomical understanding and improved surgical techniques resulted in the development of nerve-sparing surgery for radical prostatectomy. The advent of active surveillance has changed the management of low-risk disease, and chemotherapy and hormonal therapy have improved the outcomes of patients with distant disease. Ongoing research and clinical trials are expected to yield more practice-changing results in the near future.
The field of prostate cancer has been the subject of extensive research that has resulted in important discoveries and shaped our appreciation of this disease and its management. Advances in our understanding of the epidemiology, natural history, anatomy, detection, diagnosis, grading, staging, imaging, and management of prostate cancer have changed clinical practice and influenced guideline recommendations. The development of the Gleason score and subsequent modifications enabled accurate prediction of prognosis. Increased anatomical understanding and improved surgical techniques resulted in the development of nerve-sparing surgery for radical prostatectomy. The advent of active surveillance has changed the management of low-risk disease, and chemotherapy and hormonal therapy have improved the outcomes of patients with distant disease. Ongoing research and clinical trials are expected to yield more practice-changing results in the near future. In this Timeline article, the authors discuss studies that have improved our understanding of prostate cancer and influenced management of this disease.
The field of prostate cancer has been the subject of extensive research that has resulted in important discoveries and shaped our appreciation of this disease and its management. Advances in our understanding of the epidemiology, natural history, anatomy, detection, diagnosis, grading, staging, imaging, and management of prostate cancer have changed clinical practice and influenced guideline recommendations. The development of the Gleason score and subsequent modifications enabled accurate prediction of prognosis. Increased anatomical understanding and improved surgical techniques resulted in the development of nerve-sparing surgery for radical prostatectomy. The advent of active surveillance has changed the management of low-risk disease, and chemotherapy and hormonal therapy have improved the outcomes of patients with distant disease. Ongoing research and clinical trials are expected to yield more practice-changing results in the near future. In this Timeline article, the authors discuss studies that have improved our understanding of prostate cancer and influenced management of this disease.
The field of prostate cancer has been the subject of extensive research that has resulted in important discoveries and shaped our appreciation of this disease and its management. Advances in our understanding of the epidemiology, natural history, anatomy, detection, diagnosis, grading, staging, imaging, and management of prostate cancer have changed clinical practice and influenced guideline recommendations. The development of the Gleason score and subsequent modifications enabled accurate prediction of prognosis. Increased anatomical understanding and improved surgical techniques resulted in the development of nerve-sparing surgery for radical prostatectomy. The advent of active surveillance has changed the management of low-risk disease, and chemotherapy and hormonal therapy have improved the outcomes of patients with distant disease. Ongoing research and clinical trials are expected to yield more practice-changing results in the near future.
The field of prostate cancer has been the subject of extensive research that has resulted in important discoveries and shaped our appreciation of this disease and its management. Advances in our understanding of the epidemiology, natural history, anatomy, detection, diagnosis, grading, staging, imaging, and management of prostate cancer have changed clinical practice and influenced guideline recommendations. The development of the Gleason score and subsequent modifications enabled accurate prediction of prognosis. Increased anatomical understanding and improved surgical techniques resulted in the development of nerve-sparing surgery for radical prostatectomy. The advent of active surveillance has changed the management of low-risk disease, and chemotherapy and hormonal therapy have improved the outcomes of patients with distant disease. Ongoing research and clinical trials are expected to yield more practice-changing results in the near future.The field of prostate cancer has been the subject of extensive research that has resulted in important discoveries and shaped our appreciation of this disease and its management. Advances in our understanding of the epidemiology, natural history, anatomy, detection, diagnosis, grading, staging, imaging, and management of prostate cancer have changed clinical practice and influenced guideline recommendations. The development of the Gleason score and subsequent modifications enabled accurate prediction of prognosis. Increased anatomical understanding and improved surgical techniques resulted in the development of nerve-sparing surgery for radical prostatectomy. The advent of active surveillance has changed the management of low-risk disease, and chemotherapy and hormonal therapy have improved the outcomes of patients with distant disease. Ongoing research and clinical trials are expected to yield more practice-changing results in the near future.
Audience Academic
Author Crook, Juanita
Saad, Fred
Lawrentschuk, Nathan
Konety, Badrinath R.
Sathianathen, Niranjan J.
Author_xml – sequence: 1
  givenname: Niranjan J.
  orcidid: 0000-0002-3710-014X
  surname: Sathianathen
  fullname: Sathianathen, Niranjan J.
  email: niranjan19@gmail.com
  organization: Department of Urology, University of Minnesota, University of Melbourne, Department of Surgery, Urology Unit and Olivia Newton-John Cancer Research Institute Austin Health, Department of Surgical Oncology, Peter MacCallum Cancer Centre
– sequence: 2
  givenname: Badrinath R.
  surname: Konety
  fullname: Konety, Badrinath R.
  organization: Department of Urology, University of Minnesota
– sequence: 3
  givenname: Juanita
  surname: Crook
  fullname: Crook, Juanita
  organization: Department of Radiation Oncology and Developmental Radiotherapeutics, University of British Columbia
– sequence: 4
  givenname: Fred
  surname: Saad
  fullname: Saad, Fred
  organization: Division of Urology, Centre Hospitalier de l’Université de Montreal, University of Montreal
– sequence: 5
  givenname: Nathan
  surname: Lawrentschuk
  fullname: Lawrentschuk, Nathan
  organization: University of Melbourne, Department of Surgery, Urology Unit and Olivia Newton-John Cancer Research Institute Austin Health, Department of Surgical Oncology, Peter MacCallum Cancer Centre
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30065357$$D View this record in MEDLINE/PubMed
BookMark eNp9kVtLJDEQhYO4eNv9AYLIwIL40lq5dTKPIt5gYF92n0MmXdFoT1o73Q_--61hvKMmDynCd6qKc7bZeu4yMrbL4YiDtMdFcW11BdxWADVUZo1tcaOnlbIC1l9qLjbZdim3xNTK1BtsU1KppTZbbG_mc7Pw_V2ZpDy577sy-AEnweeA_U_2I_q24K-nd4f9Oz_7e3pZzf5cXJ2ezKqgDAxV0J7T8XPVeIy8ARuVRaGwMUGBNcZGCyIK38hQcx1qL61HmAsldDQ-yh12uOpL8x9GLINbpBKwbX3GbixOgOVayakCQn9_QG-7sc-0nROc16C1APlKXfsWXcqxG3oflk3diTZiOq2l0UQdfULRbXCRAlkdE_2_Exy8Edygb4eb0rXjkLpc3oP7T1uO8wU27r5P5PGje_adAL4CAjleeowvCAe3zNatsnWUrVtm65Ya80ETEoVFs2nt1H6rFCtloSn5GvtX074W_Qe33rJF
CitedBy_id crossref_primary_10_3390_cancers14122954
crossref_primary_10_1038_s41525_021_00212_w
crossref_primary_10_3390_cancers11091331
crossref_primary_10_1038_s41598_023_43019_8
crossref_primary_10_1016_j_jsxm_2020_12_016
crossref_primary_10_3390_cancers13236036
crossref_primary_10_1186_s12894_023_01373_9
crossref_primary_10_1097_MOU_0000000000000672
crossref_primary_10_1038_s41419_021_03455_8
crossref_primary_10_3390_jpm13050860
crossref_primary_10_1136_rmdopen_2019_000914
crossref_primary_10_1016_j_hoc_2019_08_017
crossref_primary_10_1080_10985549_2024_2401465
crossref_primary_10_1093_bioinformatics_btae165
crossref_primary_10_1177_03915603211016805
crossref_primary_10_1684_ecn_2019_0438
crossref_primary_10_2147_CMAR_S343321
crossref_primary_10_1002_ijc_32792
crossref_primary_10_1097_CM9_0000000000002251
crossref_primary_10_1590_s0102_865020190100000005
crossref_primary_10_3390_diagnostics8030062
crossref_primary_10_1016_j_bcp_2024_116229
crossref_primary_10_3390_ijms20051062
crossref_primary_10_3348_jksr_2023_0094
crossref_primary_10_5935_2526_8732_20210004
crossref_primary_10_3390_ijms26020631
crossref_primary_10_1038_s41585_022_00684_0
crossref_primary_10_1016_j_ccr_2022_214565
crossref_primary_10_1038_s41585_023_00786_3
crossref_primary_10_1080_13548506_2022_2115083
crossref_primary_10_1007_s12672_024_01648_z
crossref_primary_10_1016_j_ajur_2024_09_005
crossref_primary_10_1016_j_bioorg_2023_106926
crossref_primary_10_1007_s10528_023_10387_9
crossref_primary_10_1007_s13755_023_00264_5
crossref_primary_10_1016_j_cellsig_2022_110525
crossref_primary_10_18632_oncotarget_27921
crossref_primary_10_1016_j_euo_2019_07_002
crossref_primary_10_1007_s10495_023_01885_7
crossref_primary_10_1016_j_tox_2021_153051
crossref_primary_10_1007_s12672_024_01189_5
crossref_primary_10_3390_cancers13040780
crossref_primary_10_15252_msb_20199247
crossref_primary_10_3390_cancers14030596
crossref_primary_10_1016_j_tox_2022_153178
crossref_primary_10_18632_aging_103865
crossref_primary_10_1038_s41585_020_0287_y
crossref_primary_10_31083_j_fbe1501002
crossref_primary_10_1093_clinchem_hvac073
crossref_primary_10_1016_j_isci_2022_104663
crossref_primary_10_1016_j_bios_2023_115380
crossref_primary_10_1016_j_clgc_2023_10_005
crossref_primary_10_3389_fsurg_2023_1140883
crossref_primary_10_1186_s13550_020_00745_8
crossref_primary_10_1093_glycob_cwac038
crossref_primary_10_1016_j_mce_2021_111393
crossref_primary_10_1007_s00428_023_03699_z
crossref_primary_10_1016_j_trecan_2019_12_001
crossref_primary_10_1016_j_eururo_2019_10_016
crossref_primary_10_1016_j_clinbiochem_2021_03_014
crossref_primary_10_3389_fonc_2023_1136835
crossref_primary_10_1016_j_tiv_2024_105827
crossref_primary_10_1039_D2TB00448H
crossref_primary_10_3389_fendo_2024_1293953
crossref_primary_10_1038_s41598_024_65968_4
crossref_primary_10_1007_s00432_022_04213_9
crossref_primary_10_3389_fphar_2021_667474
crossref_primary_10_1007_s00259_024_06714_w
crossref_primary_10_1016_j_ejphar_2023_176007
crossref_primary_10_1038_s41594_022_00853_0
crossref_primary_10_1007_s10103_021_03386_y
crossref_primary_10_1002_cam4_6292
crossref_primary_10_1007_s11934_022_01139_0
crossref_primary_10_1038_s41585_021_00488_8
crossref_primary_10_1021_acs_analchem_1c01323
crossref_primary_10_1038_s41585_019_0183_5
crossref_primary_10_3390_cells8030201
crossref_primary_10_1038_s41391_021_00331_6
Cites_doi 10.1093/jnci/djy035
10.1016/j.juro.2017.11.095
10.1016/j.urolonc.2006.03.003
10.1016/S0022-5347(05)67512-X
10.1158/1078-0432.CCR-1146-03
10.1001/jama.281.17.1591
10.1002/pros.2990170409
10.1016/S0022-5347(17)53012-8
10.1001/jama.2014.17942
10.1056/NEJMoa1012348
10.1001/jama.2017.4413
10.1200/JCO.2008.16.9599
10.1016/S0022-5347(17)34871-1
10.1200/JCO.1987.5.6.912
10.1016/j.urology.2010.01.027
10.1016/S1470-2045(04)01384-1
10.1016/S0022-5347(05)64542-9
10.1016/S1470-2045(14)71205-7
10.1002/jmri.21824
10.1016/S0140-6736(14)60525-0
10.1001/jama.2018.3710
10.1056/NEJMoa1615869
10.1002/jmri.20793
10.1016/S0140-6736(10)61389-X
10.1158/1078-0432.CCR-07-0944
10.1200/JCO.2007.14.9021
10.1016/j.urology.2006.05.033
10.1016/S0360-3016(01)01579-6
10.1056/NEJM198710083171501
10.1158/1078-0432.CCR-06-0067
10.1016/S0022-5347(17)35233-3
10.1056/NEJMoa1201546
10.1016/S1470-2045(12)70560-0
10.1111/j.1464-410X.2009.09070.x
10.3322/caac.21254
10.1056/NEJMoa1113162
10.1001/archsurg.1941.01210140043004
10.1002/ijc.29210
10.1016/S0140-6736(16)32401-1
10.1016/S0022-5347(17)38663-9
10.1056/NEJM199104253241702
10.1056/NEJMoa0810696
10.1056/NEJMoa1212299
10.1097/01.ju.0000158155.33890.e7
10.1016/j.eururo.2013.04.019
10.1056/NEJMoa1014618
10.1001/jama.291.22.2713
10.1111/j.1365-2559.2011.04003.x
10.1056/NEJMoa0810084
10.1158/0008-5472.CAN-08-3795
10.1016/j.clgc.2013.05.004
10.1093/jnci/95.12.868
10.1200/JCO.2008.18.9563
10.1056/NEJMoa1405095
10.1111/j.1464-410X.2004.05106.x
10.1016/S0022-5347(05)66251-9
10.1046/j.1464-410X.1998.00749.x
10.1016/S0022-5347(01)63951-X
10.1093/jnci/djh141
10.1038/nrurol.2016.251
10.1001/jama.2011.1437
10.1016/S0022-5347(17)37206-3
10.1016/S0022-5347(17)40211-4
10.1200/EDBK_159244
10.1148/85.1.121
10.1056/NEJMoa1209096
10.1001/jama.280.11.969
10.1111/j.1464-410X.2008.07585.x
10.1001/archinternmed.2012.2768
10.1200/JCO.2017.35.15_suppl.LBA3
10.1016/S1470-2045(16)00107-8
10.1016/j.eururo.2017.05.011
10.1056/NEJMoa1606220
10.1016/j.brachy.2015.02.200
10.1056/NEJMoa1503747
10.1001/jama.293.17.2095
10.1001/jama.2008.864
10.1056/NEJMoa1315815
10.1148/radiology.162.2.3797645
10.1200/JCO.2015.64.9285
10.1016/j.juro.2013.04.119
10.1002/pros.2990020105
10.1111/j.1464-410X.2012.10933.x
10.1016/j.ypmed.2015.11.017
10.1001/jama.1997.03540420041027
10.1002/cncr.26169
10.1097/COC.0b013e31827e4eb9
10.1056/NEJM198908173210702
10.1016/S1470-2045(12)70379-0
10.1016/S1470-2045(11)70162-0
10.1001/jama.1995.03520310046028
10.1001/jama.296.19.2329
10.1016/j.juro.2016.03.171
10.1016/j.eururo.2016.08.065
10.1200/JCO.2005.12.922
10.1016/j.juro.2008.10.019
10.1016/j.juro.2017.04.101
10.1016/S1470-2045(16)30102-4
10.1093/jnci/90.10.766
10.1016/S0140-6736(10)62344-6
10.1001/jama.2018.0154
10.1016/j.juro.2007.01.012
10.1200/JCO.2007.13.9881
10.1016/j.juro.2014.11.096
10.1016/S0140-6736(12)61253-7
10.1056/NEJMoa1213755
10.1001/jamaoncol.2016.5465
10.1093/jnci/djj190
10.1002/pros.2990040506
10.1016/j.eururo.2014.03.011
10.1016/S0140-6736(08)61815-2
10.1056/NEJMoa1207506
10.6004/jnccn.2016.0060
10.1056/NEJMoa041318
10.1016/j.juro.2008.11.032
10.1016/j.eururo.2016.08.002
10.1089/end.2004.18.611
10.1016/j.juro.2007.11.061
10.1002/1097-0142(19930615)71:12<3975::AID-CNCR2820711229>3.0.CO;2-D
10.1200/JCO.1999.17.5.1499
10.1056/NEJMoa1209978
10.1038/nm.4053
10.59566/IJBS.2009.5201
10.3322/caac.20066
10.1016/S0140-6736(45)91030-0
10.1001/jama.280.11.975
10.1016/j.ijrobp.2004.01.023
10.1016/j.eururo.2013.08.008
10.1056/NEJMoa1215932
10.1038/nrurol.2011.50
10.1016/S1470-2045(05)70348-X
10.1056/NEJM199912093412401
10.1016/S0140-6736(05)67101-2
10.1038/nrurol.2013.195
10.1016/S0140-6736(15)01037-5
10.1016/j.eururo.2012.04.035
10.1200/JCO.2005.03.1435
10.1038/pcan.2011.59
10.1016/S0090-4295(00)00858-X
10.1016/S0140-6736(11)61095-7
10.1093/jnci/djn255
10.1056/NEJM199707313370502
10.1016/j.urolonc.2017.06.059
10.1016/S0140-6736(16)30592-X
10.1016/S1470-2045(06)70700-8
10.1016/j.eururo.2014.01.003
10.7326/0003-4819-157-2-201207170-00459
10.1002/jmri.10172
10.1200/JCO.2014.55.1192
10.1097/00005650-199807000-00007
10.2967/jnumed.115.154153
10.1056/NEJMoa040720
10.1038/pcan.2016.30
10.1007/s00259-014-2949-6
10.1038/modpathol.3800054
10.1016/S0006-291X(05)80067-1
10.1002/1097-0142(19870801)60:3+<526::AID-CNCR2820601515>3.0.CO;2-9
10.1046/j.1464-410x.2001.02275.x
10.1001/jama.299.3.289
10.1016/S0094-0143(21)01398-7
10.1001/jama.1994.03510290050036
10.1007/s00330-015-4015-6
10.1093/jnci/92.8.613
10.1038/nrurol.2015.212
10.1016/j.juro.2008.04.018
10.1097/PAS.0000000000000530
10.1056/NEJMoa1001294
10.1007/s00330-011-2377-y
10.1111/bju.12964
10.1093/jnci/94.19.1458
10.1056/NEJMoa030660
10.1016/S0022-5347(05)64051-7
10.1016/j.ijrobp.2004.08.047
10.1056/NEJMoa1801993
10.1056/NEJMoa1702900
10.1053/srao.2002.00000
10.1001/jama.1992.03480160073037
10.1111/bju.12536
10.1001/jama.2015.14905
10.1056/NEJMoa031918
10.1016/j.eururo.2012.05.068
10.1016/S0022-5347(05)65174-9
10.1111/j.1464-410X.2004.04763.x
10.1038/ncpuro1290
10.1056/NEJMoa0810095
10.1210/jc.2010-0902
10.1016/j.eururo.2016.08.003
10.1016/S1470-2045(15)00518-5
10.1016/S0090-4295(03)00243-7
ContentType Journal Article
Copyright Springer Nature Limited 2018
COPYRIGHT 2018 Nature Publishing Group
Copyright Nature Publishing Group Oct 2018
Copyright_xml – notice: Springer Nature Limited 2018
– notice: COPYRIGHT 2018 Nature Publishing Group
– notice: Copyright Nature Publishing Group Oct 2018
DBID AAYXX
CITATION
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1038/s41585-018-0060-7
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed



ProQuest One Academic Middle East (New)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1759-4820
EndPage 642
ExternalDocumentID A572996375
30065357
10_1038_s41585_018_0060_7
Genre Journal Article
Review
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID ---
0R~
29M
39C
3V.
53G
70F
7X7
88E
8FI
8FJ
AAEEF
AARCD
AAWTL
AAWYQ
AAYZH
AAZLF
ABAWZ
ABJNI
ABLJU
ABUWG
ACGFS
ADBBV
AENEX
AFFVI
AFKRA
AFSHS
AGAYW
AGHTU
AHBCP
AHMBA
AHOSX
AHSBF
AIBTJ
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ARMCB
AXYYD
BENPR
BKKNO
BPHCQ
BVXVI
CCPQU
DB5
EBS
EE.
EJD
EXGXG
F5P
FQGFK
FSGXE
FYUFA
HMCUK
HZ~
IAO
IHR
IHW
INH
INR
ITC
M1P
NNMJJ
ODYON
OVD
PQQKQ
PROAC
PSQYO
RNR
RNT
RNTTT
S70
SHXYY
SIXXV
SNYQT
SOJ
TAOOD
TBHMF
TDRGL
TEORI
TSG
UKHRP
AAYXX
AFANA
ALPWD
ATHPR
CITATION
PHGZM
PHGZT
NPM
PMFND
7XB
8FK
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c470t-c5a1111ab4daef1d08f48e24ed7c408778f802f2ad3c615c6a38ae0b2425f7af3
IEDL.DBID 7X7
ISSN 1759-4812
1759-4820
IngestDate Fri Jul 11 12:37:03 EDT 2025
Fri Jul 25 08:55:04 EDT 2025
Tue Jun 17 21:38:28 EDT 2025
Tue Jun 10 20:46:19 EDT 2025
Thu May 22 21:22:13 EDT 2025
Wed Feb 19 02:36:29 EST 2025
Tue Jul 01 03:38:49 EDT 2025
Thu Apr 24 23:00:34 EDT 2025
Fri Feb 21 02:38:08 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c470t-c5a1111ab4daef1d08f48e24ed7c408778f802f2ad3c615c6a38ae0b2425f7af3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Literature Review-3
ObjectType-Review-3
content type line 23
ORCID 0000-0002-3710-014X
PMID 30065357
PQID 2116055203
PQPubID 2041928
PageCount 16
ParticipantIDs proquest_miscellaneous_2081543940
proquest_journals_2116055203
gale_infotracmisc_A572996375
gale_infotracacademiconefile_A572996375
gale_healthsolutions_A572996375
pubmed_primary_30065357
crossref_primary_10_1038_s41585_018_0060_7
crossref_citationtrail_10_1038_s41585_018_0060_7
springer_journals_10_1038_s41585_018_0060_7
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-10-01
PublicationDateYYYYMMDD 2018-10-01
PublicationDate_xml – month: 10
  year: 2018
  text: 2018-10-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Nature reviews. Urology
PublicationTitleAbbrev Nat Rev Urol
PublicationTitleAlternate Nat Rev Urol
PublicationYear 2018
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Bolla (CR124) 2009; 360
Catalona (CR26) 1994; 151
Schroder (CR32) 2009; 360
Bibbins-Domingo, Grossman, Curry (CR39) 2017; 317
Messing (CR154) 2006; 7
Mohler (CR175) 2004; 10
Epstein, Walsh, Carmichael, Brendler (CR197) 1994; 271
Umbehr, Muntener, Hany, Sulser, Bachmann (CR77) 2013; 64
Andriole (CR31) 2009; 360
Schuessler, Kavoussi, Clayman, Vancaille (CR116) 1992; 147
Menon, Hemal (CR120) 2004; 18
Unger (CR46) 2018
Bhindi (CR35) 2015; 193
Warde (CR134) 2011; 378
Jemal (CR34) 2015; 314
Litwin (CR191) 1998; 36
Ferlay (CR2) 2015; 136
Odedina (CR12) 2009; 4
Carter (CR22) 2013; 190
McNeal (CR50) 1981; 2
Thompson (CR139) 2009; 181
Scher (CR183) 2012; 367
Partin (CR83) 1997; 277
Labrie (CR150) 1982; 5
Humphrey (CR70) 2004; 17
Keating, O’Malley, Freedland, Smith (CR160) 2013; 64
Zelefsky, Fuks, Leibel (CR135) 2002; 12
Albertsen, Hanley, Fine (CR16) 2005; 293
Szymanski, Wei, Dunn, Sanda (CR193) 2010; 76
Saad (CR189) 2004; 96
Schroder (CR41) 2012; 62
Denham (CR126) 2005; 6
Petrylak (CR166) 2004; 351
Albertsen, Hanley, Gleason, Barry (CR15) 1998; 280
Costello, Brooks, Cole (CR52) 2004; 94
Crawford (CR151) 1989; 321
Berthold, Sternberg, Tannock (CR163) 2005; 23
Fulgham (CR97) 2017; 198
Martin (CR43) 2018; 319
Wang, Valenzuela, Murphy, Chu (CR19) 1979; 17
Lippman (CR48) 2009; 301
Veldscholte (CR177) 1990; 173
Carroll (CR29) 2016; 14
Hricak (CR90) 1987; 162
Ahmed (CR96) 2017; 389
Cooperberg (CR9) 2017; 72
Abbou (CR119) 2001; 165
Carter (CR21) 1992; 267
Eiber (CR79) 2015; 55
Hamdy (CR102) 2016; 375
(CR40) 2018; 319
Fizazi (CR190) 2011; 377
Montie, Smith (CR99) 2004; 63
Walsh (CR114) 2007; 177
Yaxley (CR121) 2016; 388
Bill-Axelson (CR100) 2008; 100
Draisma (CR30) 2003; 95
CR112
Levine, Ittman, Melamed, Lepor (CR59) 1998; 159
Mottet (CR28) 2017; 71
Resnick (CR194) 2013; 368
Huggins, Stevens, Hodges (CR146) 1941; 43
de Bono (CR169) 2010; 376
Thompson (CR44) 2003; 349
Walsh, Lepor, Eggleston (CR55) 1983; 4
Potosky, Miller, Albertsen, Kramer (CR7) 1995; 273
Hu (CR65) 2012; 110
Weiner, Matulewicz, Eggener, Schaeffer (CR36) 2016; 19
Beer (CR181) 2014; 371
Shoag (CR4) 2016; 196
Bolla (CR141) 2005; 366
Berthold (CR168) 2008; 14
Penson (CR199) 2016; 34
Parker (CR187) 2013; 369
Feldman, Goldstein, Hatzichristou, Krane, McKinlay (CR195) 1994; 151
Johansson (CR17) 2004; 291
Cooner (CR24) 1990; 143
Presti (CR60) 2003; 169
Kim, Andriole (CR196) 2015; 12
Huggins, Stevens, Hodges (CR147) 1941; 43
Widmark (CR133) 2009; 373
Pilepich (CR129) 2005; 61
Steinberg, Carter, Beaty, Childs, Walsh (CR13) 1990; 17
Sweeney (CR171) 2015; 373
Tannock (CR167) 2004; 351
Rhee (CR159) 2015; 115
Sridhar (CR165) 2014; 65
CR10
Moyer (CR33) 2012; 157
Klein (CR49) 2011; 306
Newschaffer, Otani, McDonald, Penberthy (CR98) 2000; 92
Sanda (CR75) 2017
Cooperberg, Hilton, Carroll (CR88) 2011; 117
D’Amico, Chen, Renshaw, Loffredo, Kantoff (CR125) 2008; 299
Walsh, Lepor (CR54) 1987; 60
Kasivisvanathan (CR67) 2018; 378
Siegel, Miller, Jemal (CR1) 2015; 65
Parker (CR107) 2004; 5
Walker, Tran, Robinson (CR157) 2013; 11
Bolla (CR131) 1997; 337
Howard (CR6) 2012; 172
Millin (CR113) 1945; 246
Kantoff (CR200) 2010; 363
Stephenson (CR86) 2006; 98
Rezaee, Ward, Odom, Pollock (CR38) 2016; 82
Horwitz (CR127) 2008; 26
Gravis (CR170) 2013; 14
Kourambas, Angus, Hosking, Chou (CR51) 1998; 82
Bott (CR64) 2006; 68
Pilepich (CR132) 2001; 50
James (CR172) 2016; 387
Morris (CR143) 2015; 14
Wolf (CR23) 2010; 60
Lee (CR81) 2010; 105
Johansson (CR101) 2011; 12
Goldenberg, Bruchovsky (CR149) 1991; 18
Wilt (CR103) 2012; 367
Bolla (CR142) 2012; 380
Pienta, Bradley (CR178) 2006; 12
Das (CR136) 2014; 37
Glickman, Godoy, Lepor (CR122) 2009; 181
Barentsz (CR94) 2012; 22
Wright, Ellis (CR63) 2006; 24
Delahunt, Miller, Srigley, Evans, Samaratunga (CR71) 2012; 60
Young, Davis (CR57) 1926
Fleshner, Carlsson, Roobol (CR5) 2016; 14
Duchesne (CR152) 2016; 17
Cooperberg (CR87) 2005; 173
Epstein (CR73) 2016; 40
Crook (CR155) 2012; 367
Ryan (CR184) 2013; 368
Bancroft (CR14) 2014; 66
Shore (CR182) 2016; 17
Guo (CR180) 2009; 69
Wiegel (CR138) 2014; 66
Lawrentschuk, Klotz (CR106) 2011; 8
Green (CR158) 2004; 93
Boorjian, Karnes, Rangel, Bergstralh, Blute (CR80) 2008; 179
Bagshaw, Kaplan, Sagerman (CR123) 1965; 85
CR69
Kurhanewicz, Swanson, Nelson, Vigneron (CR91) 2002; 16
Wilt (CR104) 2017; 377
Saranchuk (CR115) 2005; 23
Hamilton (CR161) 2010; 95
Hu (CR37) 2017; 3
Chang, Challacombe, Lawrentschuk (CR62) 2013; 10
Grummet (CR66) 2014; 114
Tanimoto, Nakashima, Kohno, Shinmoto, Kuribayashi (CR93) 2007; 25
Saad (CR188) 2002; 94
Kattan, Wheeler, Scardino (CR85) 1999; 17
Wozniak (CR164) 1993; 71
Wei, Dunn, Litwin, Sandler, Sanda (CR192) 2000; 56
de Bono (CR198) 2011; 364
Hodge, McNeal, Stamey (CR58) 1989; 142
Brajtbord, Leapman, Cooperberg (CR89) 2017; 71
Siddiqui (CR61) 2015; 313
Thompson (CR27) 2004; 350
Tasian (CR3) 2012; 15
Guillonneau, Vallancien (CR117) 2000; 163
Fizazi (CR186) 2012; 13
Langer (CR92) 2009; 30
Carlucci, Nabizada-Pace, Samadi (CR118) 2009; 5
Tosoian (CR109) 2016; 35
Jones (CR128) 2011; 365
James (CR173) 2017; 377
Afshar-Oromieh (CR78) 2015; 42
Billis (CR72) 2008; 180
Taneja (CR76) 2004; 6
Ahmann (CR148) 1987; 5
Thompson (CR45) 2013; 369
Pound (CR18) 1999; 281
Kattan, Eastham, Stapleton, Wheeler, Scardino (CR84) 1998; 90
Patel, Klein (CR11) 2009; 6
Wymenga, Boomsma, Groenier, Piers, Mensink (CR74) 2001; 88
Ryan (CR185) 2015; 16
Kumar (CR176) 2016; 22
D’Amico (CR82) 1998; 280
Stamey (CR20) 1987; 317
Cornford (CR162) 2017; 71
Fizazi (CR174) 2017; 35
Barringer (CR56) 1922; 34
Choo (CR105) 2002; 167
Dearnaley (CR145) 2016; 17
Thompson (CR140) 2006; 296
Gaylis (CR8) 2017; 35
Vargas (CR95) 2016; 26
Gleason (CR68) 1966; 50
Wiegel (CR137) 2009; 27
Hussain (CR156) 2013; 368
Klotz (CR108) 2015; 33
Walsh, Donker (CR53) 1982; 128
Messing (CR153) 1999; 341
Antonarakis (CR179) 2014; 371
Stock, Cahlon, Cesaretti, Kollmeier, Stone (CR144) 2004; 59
Kramer (CR47) 2009; 27
Catalona (CR25) 1991; 324
Young (CR111) 2002; 168
Roach (CR130) 2008; 26
Schroder (CR42) 2014; 384
Adolfsson (CR110) 2008; 102
FT Odedina (60_CR12) 2009; 4
60_CR69
PC Walsh (60_CR55) 1983; 4
MC Wang (60_CR19) 1979; 17
WJ Catalona (60_CR26) 1994; 151
K Fizazi (60_CR174) 2017; 35
N Lawrentschuk (60_CR106) 2011; 8
MV Pilepich (60_CR129) 2005; 61
HJ Green (60_CR158) 2004; 93
SA Boorjian (60_CR80) 2008; 179
EM Messing (60_CR154) 2006; 7
AM Wolf (60_CR23) 2010; 60
EA Klein (60_CR49) 2011; 306
VA Moyer (60_CR33) 2012; 157
JI Epstein (60_CR73) 2016; 40
MA Bagshaw (60_CR123) 1965; 85
JW Saranchuk (60_CR115) 2005; 23
CC Abbou (60_CR119) 2001; 165
M Hussain (60_CR156) 2013; 368
M Bolla (60_CR142) 2012; 380
T Wiegel (60_CR137) 2009; 27
DR Berthold (60_CR163) 2005; 23
F Saad (60_CR188) 2002; 94
DL Langer (60_CR92) 2009; 30
PC Walsh (60_CR54) 1987; 60
JE Johansson (60_CR17) 2004; 291
J Kourambas (60_CR51) 1998; 82
D Dearnaley (60_CR145) 2016; 17
HH Young (60_CR57) 1926
JS Bono de (60_CR169) 2010; 376
ND James (60_CR173) 2017; 377
IM Thompson (60_CR139) 2009; 181
KK Hodge (60_CR58) 1989; 142
ND James (60_CR172) 2016; 387
R Choo (60_CR105) 2002; 167
PF Fulgham (60_CR97) 2017; 198
H Rhee (60_CR159) 2015; 115
HI Scher (60_CR183) 2012; 367
A Jemal (60_CR34) 2015; 314
B Delahunt (60_CR71) 2012; 60
DP Petrylak (60_CR166) 2004; 351
G Draisma (60_CR30) 2003; 95
K Fizazi (60_CR186) 2012; 13
US Preventive Services Task Force (60_CR40) 2018; 319
PC Albertsen (60_CR16) 2005; 293
AJ Stephenson (60_CR86) 2006; 98
F Labrie (60_CR150) 1982; 5
S Das (60_CR136) 2014; 37
MJ Zelefsky (60_CR135) 2002; 12
GM Duchesne (60_CR152) 2016; 17
AB Weiner (60_CR36) 2016; 19
PW Kantoff (60_CR200) 2010; 363
SE Lee (60_CR81) 2010; 105
HA Vargas (60_CR95) 2016; 26
MJ Resnick (60_CR194) 2013; 368
DF Gleason (60_CR68) 1966; 50
EK Bancroft (60_CR14) 2014; 66
EM Horwitz (60_CR127) 2008; 26
PC Walsh (60_CR53) 1982; 128
ES Antonarakis (60_CR179) 2014; 371
BS Barringer (60_CR56) 1922; 34
J Ferlay (60_CR2) 2015; 136
JM Unger (60_CR46) 2018
C Huggins (60_CR147) 1941; 43
JE McNeal (60_CR50) 1981; 2
M Menon (60_CR120) 2004; 18
M Bolla (60_CR124) 2009; 360
CJ Ryan (60_CR185) 2015; 16
TA Stamey (60_CR20) 1987; 317
EM Messing (60_CR153) 1999; 341
SS Taneja (60_CR76) 2004; 6
TJ Wilt (60_CR103) 2012; 367
K Bibbins-Domingo (60_CR39) 2017; 317
MR Cooperberg (60_CR87) 2005; 173
HB Carter (60_CR22) 2013; 190
P Cornford (60_CR162) 2017; 71
CR Pound (60_CR18) 1999; 281
FH Schroder (60_CR42) 2014; 384
E Johansson (60_CR101) 2011; 12
IM Thompson (60_CR140) 2006; 296
JS Bono de (60_CR198) 2011; 364
JE Montie (60_CR99) 2004; 63
RG Stock (60_CR144) 2004; 59
A Billis (60_CR72) 2008; 180
JW Denham (60_CR126) 2005; 6
FD Gaylis (60_CR8) 2017; 35
B Guillonneau (60_CR117) 2000; 163
PC Walsh (60_CR114) 2007; 177
60_CR10
Jonathan S. Brajtbord (60_CR89) 2017; 71
FR Ahmann (60_CR148) 1987; 5
C Parker (60_CR187) 2013; 369
FC Hamdy (60_CR102) 2016; 375
V Kasivisvanathan (60_CR67) 2018; 378
GE Tasian (60_CR3) 2012; 15
FH Schroder (60_CR41) 2012; 62
M Eiber (60_CR79) 2015; 55
LF Wymenga (60_CR74) 2001; 88
Z Guo (60_CR180) 2009; 69
NL Keating (60_CR160) 2013; 64
GD Steinberg (60_CR13) 1990; 17
WW Schuessler (60_CR116) 1992; 147
MW Kattan (60_CR84) 1998; 90
PR Carroll (60_CR29) 2016; 14
PA Humphrey (60_CR70) 2004; 17
K Fleshner (60_CR5) 2016; 14
AR Patel (60_CR11) 2009; 6
DF Penson (60_CR199) 2016; 34
JC Hu (60_CR37) 2017; 3
SL Goldenberg (60_CR149) 1991; 18
H Hricak (60_CR90) 1987; 162
JL Mohler (60_CR175) 2004; 10
G Gravis (60_CR170) 2013; 14
CJ Ryan (60_CR184) 2013; 368
L Glickman (60_CR122) 2009; 181
AJ Wozniak (60_CR164) 1993; 71
SM Lippman (60_CR48) 2009; 301
EJ Hamilton (60_CR161) 2010; 95
MA Levine (60_CR59) 1998; 159
A Bill-Axelson (60_CR100) 2008; 100
FH Schroder (60_CR32) 2009; 360
KM Szymanski (60_CR193) 2010; 76
TM Beer (60_CR181) 2014; 371
EH Kim (60_CR196) 2015; 12
DH Howard (60_CR6) 2012; 172
HU Ahmed (60_CR96) 2017; 389
A Kumar (60_CR176) 2016; 22
MR Cooperberg (60_CR9) 2017; 72
GL Andriole (60_CR31) 2009; 360
T Millin (60_CR113) 1945; 246
Y Hu (60_CR65) 2012; 110
JP Grummet (60_CR66) 2014; 114
WJ Catalona (60_CR25) 1991; 324
AV D’Amico (60_CR82) 1998; 280
IF Tannock (60_CR167) 2004; 351
JI Epstein (60_CR197) 1994; 271
MW Kattan (60_CR85) 1999; 17
C Huggins (60_CR146) 1941; 43
BS Kramer (60_CR47) 2009; 27
L Klotz (60_CR108) 2015; 33
HA Feldman (60_CR195) 1994; 151
F Saad (60_CR189) 2004; 96
HH Young (60_CR111) 2002; 168
JC Presti (60_CR60) 2003; 169
JW Yaxley (60_CR121) 2016; 388
MH Umbehr (60_CR77) 2013; 64
M Bolla (60_CR131) 1997; 337
A Afshar-Oromieh (60_CR78) 2015; 42
RM Martin (60_CR43) 2018; 319
LM Walker (60_CR157) 2013; 11
A Tanimoto (60_CR93) 2007; 25
M Roach (60_CR130) 2008; 26
JO Barentsz (60_CR94) 2012; 22
IM Thompson (60_CR45) 2013; 369
MG Sanda (60_CR75) 2017
P Warde (60_CR134) 2011; 378
CJ Newschaffer (60_CR98) 2000; 92
JL Wright (60_CR63) 2006; 24
K Fizazi (60_CR190) 2011; 377
CU Jones (60_CR128) 2011; 365
AL Potosky (60_CR7) 1995; 273
AW Partin (60_CR83) 1997; 277
A Widmark (60_CR133) 2009; 373
AJ Costello (60_CR52) 2004; 94
RL Siegel (60_CR1) 2015; 65
JJ Tosoian (60_CR109) 2016; 35
IM Thompson (60_CR27) 2004; 350
M Bolla (60_CR141) 2005; 366
N Mottet (60_CR28) 2017; 71
PC Albertsen (60_CR15) 1998; 280
J Veldscholte (60_CR177) 1990; 173
DTS Chang (60_CR62) 2013; 10
TJ Wilt (60_CR104) 2017; 377
CJ Sweeney (60_CR171) 2015; 373
IM Thompson (60_CR44) 2003; 349
ME Rezaee (60_CR38) 2016; 82
DR Berthold (60_CR168) 2008; 14
ND Shore (60_CR182) 2016; 17
ED Crawford (60_CR151) 1989; 321
B Bhindi (60_CR35) 2015; 193
T Wiegel (60_CR138) 2014; 66
MV Pilepich (60_CR132) 2001; 50
J Shoag (60_CR4) 2016; 196
WJ Morris (60_CR143) 2015; 14
AV D’Amico (60_CR125) 2008; 299
KJ Pienta (60_CR178) 2006; 12
60_CR112
MM Siddiqui (60_CR61) 2015; 313
MR Cooperberg (60_CR88) 2011; 117
J Adolfsson (60_CR110) 2008; 102
JM Crook (60_CR155) 2012; 367
WH Cooner (60_CR24) 1990; 143
JT Wei (60_CR192) 2000; 56
JR Carlucci (60_CR118) 2009; 5
SS Sridhar (60_CR165) 2014; 65
H Carter (60_CR21) 1992; 267
J Kurhanewicz (60_CR91) 2002; 16
MS Litwin (60_CR191) 1998; 36
C Parker (60_CR107) 2004; 5
SR Bott (60_CR64) 2006; 68
References_xml – volume: 8
  start-page: 312
  year: 2011
  end-page: 320
  ident: CR106
  article-title: Active surveillance for low-risk prostate cancer: an update
  publication-title: Nat. Rev. Urol.
– volume: 115
  start-page: 3
  issue: Suppl. 5
  year: 2015
  end-page: 13
  ident: CR159
  article-title: Adverse effects of androgen-deprivation therapy in prostate cancer and their management
  publication-title: BJU Int.
– volume: 167
  start-page: 1664
  year: 2002
  end-page: 1669
  ident: CR105
  article-title: Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression
  publication-title: J. Urol.
– volume: 71
  start-page: 630
  year: 2017
  end-page: 642
  ident: CR162
  article-title: EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer
  publication-title: Eur. Urol.
– volume: 173
  start-page: 1938
  year: 2005
  end-page: 1942
  ident: CR87
  article-title: The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy
  publication-title: J. Urol.
– volume: 14
  start-page: S12
  year: 2015
  ident: CR143
  article-title: Low-dose-rate brachytherapy is superior to dose-escalated EBRT for unfavourable risk prostate cancer: the results of the ASCENDE-RT* randomized control trial
  publication-title: Brachytherapy
– volume: 351
  start-page: 1502
  year: 2004
  end-page: 1512
  ident: CR167
  article-title: Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
  publication-title: N. Engl. J. Med.
– volume: 60
  start-page: 526
  year: 1987
  end-page: 537
  ident: CR54
  article-title: The role of radical prostatectomy in the management of prostatic cancer
  publication-title: Cancer
– volume: 360
  start-page: 2516
  year: 2009
  end-page: 2527
  ident: CR124
  article-title: Duration of androgen suppression in the treatment of prostate cancer
  publication-title: N. Engl. J. Med.
– volume: 12
  start-page: 229
  year: 2002
  end-page: 237
  ident: CR135
  article-title: Intensity-modulated radiation therapy for prostate cancer
  publication-title: Semin. Radiat. Oncol.
– volume: 5
  start-page: 201
  year: 2009
  end-page: 208
  ident: CR118
  article-title: Robot-assisted laparoscopic radical prostatectomy: technique and outcomes of 700 cases
  publication-title: Int. J. Biomed. Sci.
– volume: 181
  start-page: 731
  year: 2009
  end-page: 735
  ident: CR122
  article-title: Changes in continence and erectile function between 2 and 4 years after radical prostatectomy
  publication-title: J. Urol.
– volume: 360
  start-page: 1310
  year: 2009
  end-page: 1319
  ident: CR31
  article-title: Mortality results from a randomized prostate-cancer screening trial
  publication-title: N. Engl. J. Med.
– volume: 369
  start-page: 603
  year: 2013
  end-page: 610
  ident: CR45
  article-title: Long-term survival of participants in the prostate cancer prevention trial
  publication-title: N. Engl. J. Med.
– volume: 179
  start-page: 1354
  year: 2008
  end-page: 1360
  ident: CR80
  article-title: Mayo Clinic validation of the D’amico risk group classification for predicting survival following radical prostatectomy
  publication-title: J. Urol.
– volume: 34
  start-page: 2098
  year: 2016
  end-page: 2106
  ident: CR199
  article-title: Enzalutamide versus bicalutamide in castration-resistant prostate cancer: the STRIVE Trial
  publication-title: J. Clin. Oncol.
– volume: 291
  start-page: 2713
  year: 2004
  end-page: 2719
  ident: CR17
  article-title: Natural history of early, localized prostate cancer
  publication-title: JAMA
– volume: 63
  start-page: 207
  year: 2004
  end-page: 209
  ident: CR99
  article-title: Whitmoreisms: memorable quotes from Willet F. Whitmore Jr, M. D
  publication-title: Urology
– volume: 64
  start-page: 159
  year: 2013
  end-page: 166
  ident: CR160
  article-title: Does comorbidity influence the risk of myocardial infarction or diabetes during androgen-deprivation therapy for prostate cancer?
  publication-title: Eur. Urol.
– volume: 71
  start-page: 3975
  year: 1993
  end-page: 3978
  ident: CR164
  article-title: Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A Southwest Oncology Group study
  publication-title: Cancer
– volume: 117
  start-page: 5039
  year: 2011
  end-page: 5046
  ident: CR88
  article-title: The CAPRA-S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy
  publication-title: Cancer
– volume: 16
  start-page: 152
  year: 2015
  end-page: 160
  ident: CR185
  article-title: Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
  publication-title: Lancet Oncol.
– volume: 280
  start-page: 975
  year: 1998
  end-page: 980
  ident: CR15
  article-title: Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer
  publication-title: JAMA
– volume: 157
  start-page: 120
  year: 2012
  end-page: 134
  ident: CR33
  article-title: Screening for prostate cancer: US Preventive Services Task Force recommendation statement
  publication-title: Ann. Intern. Med.
– volume: 30
  start-page: 327
  year: 2009
  end-page: 334
  ident: CR92
  article-title: Prostate cancer detection with multi-parametric MRI: Logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI
  publication-title: J. Magnet. Resonance Imag.
– volume: 10
  start-page: 440
  year: 2004
  end-page: 448
  ident: CR175
  article-title: The androgen axis in recurrent prostate cancer
  publication-title: Clin. Cancer Res.
– volume: 389
  start-page: 815
  year: 2017
  end-page: 822
  ident: CR96
  article-title: Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
  publication-title: Lancet
– volume: 95
  start-page: 868
  year: 2003
  end-page: 878
  ident: CR30
  article-title: Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer
  publication-title: J. Natl Cancer Inst.
– volume: 246
  start-page: 693
  year: 1945
  end-page: 696
  ident: CR113
  article-title: Retropubic prostatectomy a new extravesical technique: report on 20 cases
  publication-title: Lancet.
– volume: 17
  start-page: 337
  year: 1990
  end-page: 347
  ident: CR13
  article-title: Family history and the risk of prostate cancer
  publication-title: Prostate
– volume: 181
  start-page: 956
  year: 2009
  end-page: 962
  ident: CR139
  article-title: Adjuvant radiotherapy for pathologic T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial
  publication-title: J. Urol.
– volume: 151
  start-page: 54
  year: 1994
  end-page: 61
  ident: CR195
  article-title: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study
  publication-title: J. Urol.
– volume: 71
  start-page: 618
  year: 2017
  end-page: 629
  ident: CR28
  article-title: EAU-ESTRO-SIOG Guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent
  publication-title: Eur. Urol.
– ident: CR10
– volume: 36
  start-page: 1002
  year: 1998
  end-page: 1012
  ident: CR191
  article-title: The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure
  publication-title: Med. Care.
– volume: 12
  start-page: 891
  year: 2011
  end-page: 899
  ident: CR101
  article-title: Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial
  publication-title: Lancet Oncol.
– volume: 143
  start-page: 1146
  year: 1990
  end-page: 1152
  ident: CR24
  article-title: Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen
  publication-title: J. Urol.
– volume: 110
  start-page: 812
  year: 2012
  end-page: 820
  ident: CR65
  article-title: A biopsy simulation study to assess the accuracy of several transrectal ultrasonography (TRUS)-biopsy strategies compared with template prostate mapping biopsies in patients who have undergone radical prostatectomy
  publication-title: BJU Int.
– volume: 368
  start-page: 436
  year: 2013
  end-page: 445
  ident: CR194
  article-title: Long-term functional outcomes after treatment for localized prostate cancer
  publication-title: N. Engl. J. Med.
– ident: CR69
– volume: 172
  start-page: 1267
  year: 2012
  end-page: 1268
  ident: CR6
  article-title: Declines in prostate cancer incidence after changes in screening recommendations
  publication-title: Arch. Intern. Med.
– volume: 373
  start-page: 737
  year: 2015
  end-page: 746
  ident: CR171
  article-title: Chemohormonal therapy in metastatic hormone-sensitive prostate cancer
  publication-title: N. Engl. J. Med.
– volume: 371
  start-page: 1028
  year: 2014
  end-page: 1038
  ident: CR179
  article-title: AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer
  publication-title: N. Engl. J. Med.
– volume: 10
  start-page: 690
  year: 2013
  ident: CR62
  article-title: Transperineal biopsy of the prostate — is this the future?
  publication-title: Nat. Rev. Urol.
– volume: 92
  start-page: 613
  year: 2000
  end-page: 621
  ident: CR98
  article-title: Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort
  publication-title: J. Natl Cancer Inst.
– volume: 71
  start-page: 705
  issue: 5
  year: 2017
  end-page: 709
  ident: CR89
  article-title: The CAPRA Score at 10 Years: Contemporary Perspectives and Analysis of Supporting Studies
  publication-title: European Urology
– volume: 319
  start-page: 883
  year: 2018
  end-page: 895
  ident: CR43
  article-title: Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the cap randomized clinical trial
  publication-title: JAMA
– volume: 26
  start-page: 2497
  year: 2008
  end-page: 2504
  ident: CR127
  article-title: Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer
  publication-title: J. Clin. Oncol.
– volume: 65
  start-page: 5
  year: 2015
  end-page: 29
  ident: CR1
  article-title: Cancer statistics, 2015
  publication-title: CA Cancer J. Clin.
– volume: 27
  start-page: 1502
  year: 2009
  end-page: 1516
  ident: CR47
  article-title: Use of 5-α-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline
  publication-title: J. Clin. Oncol.
– volume: 363
  start-page: 411
  year: 2010
  end-page: 422
  ident: CR200
  article-title: Sipuleucel-T immunotherapy for castration-resistant prostate cancer
  publication-title: N. Engl. J. Med.
– volume: 35
  start-page: e235
  year: 2016
  end-page: e245
  ident: CR109
  article-title: Active surveillance of prostate cancer: use, outcomes, imaging, and diagnostic tools
  publication-title: Am. Soc. Clin. Oncol.
– volume: 68
  start-page: 1037
  year: 2006
  end-page: 1041
  ident: CR64
  article-title: Extensive transperineal template biopsies of prostate: modified technique and results
  publication-title: Urology
– volume: 376
  start-page: 1147
  year: 2010
  end-page: 1154
  ident: CR169
  article-title: Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
  publication-title: Lancet
– volume: 351
  start-page: 1513
  year: 2004
  end-page: 1520
  ident: CR166
  article-title: Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
  publication-title: N. Engl. J. Med.
– year: 1926
  ident: CR57
  publication-title: Young’s Practice of Urology
– volume: 13
  start-page: 983
  year: 2012
  end-page: 992
  ident: CR186
  article-title: Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
  publication-title: Lancet Oncol.
– volume: 55
  start-page: 668
  year: 2015
  end-page: 674
  ident: CR79
  article-title: Evaluation of hybrid 68Ga-PSMA-ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy
  publication-title: J. Nucl. Med.
– volume: 56
  start-page: 899
  year: 2000
  end-page: 905
  ident: CR192
  article-title: Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer
  publication-title: Urology
– volume: 313
  start-page: 390
  year: 2015
  end-page: 397
  ident: CR61
  article-title: Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer
  publication-title: JAMA
– volume: 177
  start-page: 1632
  year: 2007
  end-page: 1635
  ident: CR114
  article-title: The discovery of the cavernous nerves and development of nerve sparing radical retropubic prostatectomy
  publication-title: J. Urol.
– volume: 64
  start-page: 106
  year: 2013
  end-page: 117
  ident: CR77
  article-title: The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis
  publication-title: Eur. Urol.
– volume: 369
  start-page: 213
  year: 2013
  end-page: 223
  ident: CR187
  article-title: Alpha emitter radium-223 and survival in metastatic prostate cancer
  publication-title: N. Engl. J. Med.
– volume: 365
  start-page: 107
  year: 2011
  end-page: 118
  ident: CR128
  article-title: Radiotherapy and short-term androgen deprivation for localized prostate cancer
  publication-title: N. Engl. J. Med.
– volume: 341
  start-page: 1781
  year: 1999
  end-page: 1788
  ident: CR153
  article-title: Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer
  publication-title: N. Engl. J. Med.
– volume: 43
  start-page: 209
  year: 1941
  end-page: 223
  ident: CR147
  article-title: Studies on prostatic cancer. The effect of castration, of oestrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate
  publication-title: Arch. Surg.
– volume: 293
  start-page: 2095
  year: 2005
  end-page: 2101
  ident: CR16
  article-title: 20-year outcomes following conservative management of clinically localized prostate cancer
  publication-title: JAMA
– volume: 366
  start-page: 572
  year: 2005
  end-page: 578
  ident: CR141
  article-title: Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)
  publication-title: Lancet
– volume: 82
  start-page: 408
  year: 1998
  end-page: 410
  ident: CR51
  article-title: A histological study of Denonvilliers’ fascia and its relationship to the neurovascular bundle
  publication-title: Br. J. Urol.
– volume: 14
  start-page: 2763
  year: 2008
  end-page: 2767
  ident: CR168
  article-title: Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: relationships between prostate-specific antigen, pain, and quality of life response and survival in the TAX-327 study
  publication-title: Clin. Cancer Res.
– volume: 98
  start-page: 715
  year: 2006
  end-page: 717
  ident: CR86
  article-title: Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
  publication-title: J. Natl Cancer Inst.
– volume: 337
  start-page: 295
  year: 1997
  end-page: 300
  ident: CR131
  article-title: Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
  publication-title: N. Engl. J. Med.
– volume: 66
  start-page: 489
  year: 2014
  end-page: 499
  ident: CR14
  article-title: Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study
  publication-title: Eur. Urol.
– volume: 15
  start-page: 189
  year: 2012
  end-page: 194
  ident: CR3
  article-title: PSA screening: determinants of primary-care physician practice patterns
  publication-title: Prostate Cancer Prostat. Dis.
– volume: 364
  start-page: 1995
  year: 2011
  end-page: 2005
  ident: CR198
  article-title: Abiraterone and increased survival in metastatic prostate cancer
  publication-title: N. Engl. J. Med.
– volume: 35
  start-page: 663.e1
  year: 2017
  end-page: 663
  ident: CR8
  article-title: Change in prostate cancer presentation coinciding with USPSTF screening recommendations at a community-based urology practice
  publication-title: Urol. Oncol.
– volume: 173
  start-page: 534
  year: 1990
  end-page: 540
  ident: CR177
  article-title: A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 169
  start-page: 125
  year: 2003
  end-page: 129
  ident: CR60
  article-title: Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study
  publication-title: J. Urol.
– volume: 60
  start-page: 70
  year: 2010
  end-page: 98
  ident: CR23
  article-title: American Cancer Society guideline for the early detection of prostate cancer: update 2010
  publication-title: CA Cancer J. Clin.
– volume: 163
  start-page: 1643
  year: 2000
  end-page: 1649
  ident: CR117
  article-title: Laparoscopic radical prostatectomy: the Montsouris technique
  publication-title: J. Urol.
– volume: 136
  start-page: E359
  year: 2015
  end-page: E386
  ident: CR2
  article-title: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012
  publication-title: Int. J. Cancer.
– volume: 4
  issue: Suppl. 1
  year: 2009
  ident: CR12
  article-title: Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa
  publication-title: Infect. Agent Cancer.
– volume: 17
  start-page: 727
  year: 2016
  end-page: 737
  ident: CR152
  article-title: Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01–03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial
  publication-title: Lancet Oncol.
– volume: 296
  start-page: 2329
  year: 2006
  end-page: 2335
  ident: CR140
  article-title: Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial
  publication-title: JAMA
– volume: 350
  start-page: 2239
  year: 2004
  end-page: 2246
  ident: CR27
  article-title: Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter
  publication-title: N. Engl. J. Med.
– volume: 180
  start-page: 548
  year: 2008
  end-page: 552
  ident: CR72
  article-title: The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies
  publication-title: J. Urol.
– volume: 17
  start-page: 1047
  year: 2016
  end-page: 1060
  ident: CR145
  article-title: Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
  publication-title: Lancet Oncol.
– volume: 384
  start-page: 2027
  year: 2014
  end-page: 2035
  ident: CR42
  article-title: Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
  publication-title: Lancet
– volume: 26
  start-page: 585
  year: 2008
  end-page: 591
  ident: CR130
  article-title: Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610
  publication-title: J. Clin. Oncol.
– volume: 95
  start-page: E456
  year: 2010
  end-page: 463
  ident: CR161
  article-title: Structural decay of bone microarchitecture in men with prostate cancer treated with androgen deprivation therapy
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 314
  start-page: 2054
  year: 2015
  end-page: 2061
  ident: CR34
  article-title: Prostate cancer incidence and psa testing patterns in relation to uspstf screening recommendations
  publication-title: JAMA
– volume: 373
  start-page: 301
  year: 2009
  end-page: 308
  ident: CR133
  article-title: Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
  publication-title: Lancet
– volume: 19
  start-page: 395
  year: 2016
  end-page: 397
  ident: CR36
  article-title: Increasing incidence of metastatic prostate cancer in the United States (2004–2013)
  publication-title: Prostate Cancer Prostatic Dis.
– volume: 317
  start-page: 909
  year: 1987
  end-page: 916
  ident: CR20
  article-title: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate
  publication-title: N. Engl. J. Med.
– volume: 88
  start-page: 226
  year: 2001
  end-page: 230
  ident: CR74
  article-title: Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase
  publication-title: BJU Int.
– volume: 62
  start-page: 745
  year: 2012
  end-page: 752
  ident: CR41
  article-title: Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)
  publication-title: Eur. Urol.
– volume: 43
  start-page: 209
  year: 1941
  end-page: 223
  ident: CR146
  article-title: Studies on prostatic cancer. The effects of castration on advanced carcinoma of the prostate gland
  publication-title: Arch. Surg.
– volume: 17
  start-page: 153
  year: 2016
  end-page: 163
  ident: CR182
  article-title: Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study
  publication-title: Lancet Oncol.
– volume: 37
  start-page: 616
  year: 2014
  end-page: 623
  ident: CR136
  article-title: Comparison of image-guided radiotherapy technologies for prostate cancer
  publication-title: Am. J. Clin. Oncol.
– volume: 33
  start-page: 272
  year: 2015
  end-page: 277
  ident: CR108
  article-title: Long-term follow-up of a large active surveillance cohort of patients with prostate cancer
  publication-title: J. Clin. Oncol.
– volume: 198
  start-page: 832
  year: 2017
  end-page: 838
  ident: CR97
  article-title: AUA policy statement on the use of multiparametric magnetic resonance imaging in the diagnosis, staging and management of prostate cancer
  publication-title: J. Urol.
– volume: 190
  start-page: 419
  year: 2013
  end-page: 426
  ident: CR22
  article-title: Early detection of prostate cancer: AUA Guideline
  publication-title: J. Urol.
– volume: 162
  start-page: 331
  year: 1987
  end-page: 336
  ident: CR90
  article-title: Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging
  publication-title: Radiology
– volume: 378
  start-page: 2104
  year: 2011
  end-page: 2111
  ident: CR134
  article-title: Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial
  publication-title: Lancet
– volume: 367
  start-page: 1187
  year: 2012
  end-page: 1197
  ident: CR183
  article-title: Increased survival with enzalutamide in prostate cancer after chemotherapy
  publication-title: N. Engl. J. Med.
– volume: 22
  start-page: 369
  year: 2016
  end-page: 378
  ident: CR176
  article-title: Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
  publication-title: Nat. Med.
– volume: 65
  start-page: 289
  year: 2014
  end-page: 299
  ident: CR165
  article-title: Castration-resistant prostate cancer: from new pathophysiology to new treatment
  publication-title: Eur. Urol.
– volume: 168
  start-page: 914
  year: 2002
  end-page: 921
  ident: CR111
  article-title: The early diagnosis and radical cure of carcinoma of the prostate. Being a study of 40 cases and presentation of a radical operation which was carried out in four cases. 1905
  publication-title: J. Urol.
– volume: 14
  start-page: 509
  year: 2016
  end-page: 519
  ident: CR29
  article-title: NCCN Guidelines insights: prostate cancer early detection, version 2.2016
  publication-title: J. Natl Compr. Cancer Netw.
– volume: 299
  start-page: 289
  year: 2008
  end-page: 295
  ident: CR125
  article-title: Androgen suppression and radiation versus radiation alone for prostate cancer: a randomized trial
  publication-title: JAMA
– volume: 24
  start-page: 492
  year: 2006
  end-page: 495
  ident: CR63
  article-title: Improved prostate cancer detection with anterior apical prostate biopsies
  publication-title: Urol. Oncol.
– volume: 66
  start-page: 243
  year: 2014
  end-page: 250
  ident: CR138
  article-title: Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial
  publication-title: Eur. Urol.
– ident: CR112
– volume: 22
  start-page: 746
  year: 2012
  end-page: 757
  ident: CR94
  article-title: ESUR prostate MR guidelines 2012
  publication-title: Eur. Radiol.
– volume: 102
  start-page: 10
  year: 2008
  end-page: 14
  ident: CR110
  article-title: Watchful waiting and active surveillance: the current position
  publication-title: BJU Int.
– volume: 377
  start-page: 813
  year: 2011
  end-page: 822
  ident: CR190
  article-title: Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
  publication-title: Lancet
– volume: 27
  start-page: 2924
  year: 2009
  end-page: 2930
  ident: CR137
  article-title: Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95
  publication-title: J. Clin. Oncol.
– year: 2018
  ident: CR46
  article-title: Using medicare claims to examine long-term prostate cancer risk of finasteride in the prostate cancer prevention trial
  publication-title: Natl Cancer Inst.
  doi: 10.1093/jnci/djy035
– volume: 69
  start-page: 2305
  year: 2009
  end-page: 2313
  ident: CR180
  article-title: A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth
  publication-title: Cancer Res.
– volume: 72
  start-page: 326
  year: 2017
  end-page: 328
  ident: CR9
  article-title: The New US Preventive Services Task Force “C” draft recommendation for prostate cancer screening
  publication-title: Eur. Urol.
– volume: 93
  start-page: 975
  year: 2004
  end-page: 979
  ident: CR158
  article-title: Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial
  publication-title: BJU Int.
– volume: 94
  start-page: 1458
  year: 2002
  end-page: 1468
  ident: CR188
  article-title: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma
  publication-title: J. Natl Cancer Inst.
– volume: 142
  start-page: 66
  year: 1989
  end-page: 70
  ident: CR58
  article-title: Ultrasound guided transrectal core biopsies of the palpably abnormal prostate
  publication-title: J. Urol.
– volume: 60
  start-page: 75
  year: 2012
  end-page: 86
  ident: CR71
  article-title: Gleason grading: past, present and future
  publication-title: Histopathology
– volume: 159
  start-page: 471
  year: 1998
  end-page: 475
  ident: CR59
  article-title: Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer
  publication-title: J. Urol.
– volume: 16
  start-page: 451
  year: 2002
  end-page: 463
  ident: CR91
  article-title: Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer
  publication-title: J. Magnet. Resonance Imag.
– volume: 375
  start-page: 1415
  year: 2016
  end-page: 1424
  ident: CR102
  article-title: 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer
  publication-title: N. Engl. J. Med.
– volume: 17
  start-page: 159
  year: 1979
  end-page: 163
  ident: CR19
  article-title: Purification of a human prostate specific antigen
  publication-title: Invest. Urol.
– volume: 96
  start-page: 879
  year: 2004
  end-page: 882
  ident: CR189
  article-title: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer
  publication-title: J. Natl Cancer Inst.
– volume: 76
  start-page: 1245
  year: 2010
  end-page: 1250
  ident: CR193
  article-title: Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument (epic-26) for measuring health-related quality of life among prostate cancer survivors
  publication-title: Urology
– volume: 193
  start-page: 1519
  year: 2015
  end-page: 1524
  ident: CR35
  article-title: Impact of the US Preventive Services Task Force recommendations against prostate specific antigen screening on prostate biopsy and cancer detection rates
  publication-title: J. Urol.
– volume: 11
  start-page: 375
  year: 2013
  end-page: 384
  ident: CR157
  article-title: Luteinizing hormone — releasing hormone agonists: a quick reference for prevalence rates of potential adverse effects
  publication-title: Clin. Genitourin. Cancer
– volume: 7
  start-page: 472
  year: 2006
  end-page: 479
  ident: CR154
  article-title: Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy
  publication-title: Lancet Oncol.
– volume: 368
  start-page: 1314
  year: 2013
  end-page: 1325
  ident: CR156
  article-title: Intermittent versus continuous androgen deprivation in prostate cancer
  publication-title: N. Engl. J. Med.
– volume: 35
  start-page: LBA3
  year: 2017
  ident: CR174
  article-title: LATITUDE: a phase III, double-blind, randomized trial of androgen deprivation therapy with abiraterone acetate plus prednisone or placebos in newly diagnosed high-risk metastatic hormone-naive prostate cancer
  publication-title: J. Clin. Oncol.
– volume: 25
  start-page: 146
  year: 2007
  end-page: 152
  ident: CR93
  article-title: Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging
  publication-title: J. Magnet. Resonance Imag.
– year: 2017
  ident: CR75
  article-title: Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options
  publication-title: J. Urol.
  doi: 10.1016/j.juro.2017.11.095
– volume: 34
  start-page: 168
  year: 1922
  end-page: 176
  ident: CR56
  article-title: Carcinoma of the prostate
  publication-title: Surg. Gynecol. Obstet.
– volume: 105
  start-page: 1526
  year: 2010
  end-page: 1530
  ident: CR81
  article-title: Application of the Epstein criteria for prediction of clinically insignificant prostate cancer in Korean men
  publication-title: BJU Int.
– volume: 26
  start-page: 1606
  year: 2016
  end-page: 1612
  ident: CR95
  article-title: Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference
  publication-title: Eur. Radiol.
– volume: 50
  start-page: 1243
  year: 2001
  end-page: 1252
  ident: CR132
  article-title: Phase III radiation therapy oncology group (RTOG) trial 86–10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
– volume: 360
  start-page: 1320
  year: 2009
  end-page: 1328
  ident: CR32
  article-title: Screening and prostate-cancer mortality in a randomized European study
  publication-title: N. Engl. J. Med.
– volume: 387
  start-page: 1163
  year: 2016
  end-page: 1177
  ident: CR172
  article-title: Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
  publication-title: Lancet.
– volume: 371
  start-page: 424
  year: 2014
  end-page: 433
  ident: CR181
  article-title: Enzalutamide in metastatic prostate cancer before chemotherapy
  publication-title: N. Engl. J. Med.
– volume: 6
  start-page: 87
  year: 2009
  ident: CR11
  article-title: Risk factors for prostate cancer
  publication-title: Nat. Clin. Practice Urol.
– volume: 90
  start-page: 766
  year: 1998
  end-page: 771
  ident: CR84
  article-title: A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
  publication-title: J. Natl Cancer Inst.
– volume: 380
  start-page: 2018
  year: 2012
  end-page: 2027
  ident: CR142
  article-title: Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
  publication-title: Lancet
– volume: 321
  start-page: 419
  year: 1989
  end-page: 424
  ident: CR151
  article-title: A controlled trial of leuprolide with and without flutamide in prostatic carcinoma
  publication-title: N. Engl. J. Med.
– volume: 273
  start-page: 548
  year: 1995
  end-page: 552
  ident: CR7
  article-title: The role of increasing detection in the rising incidence of prostate cancer
  publication-title: JAMA
– volume: 306
  start-page: 1549
  year: 2011
  end-page: 1556
  ident: CR49
  article-title: Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
  publication-title: JAMA
– volume: 147
  start-page: 246A
  year: 1992
  ident: CR116
  article-title: Laparoscopic radical prostatectomy: initial case report
  publication-title: J. Urol.
– volume: 3
  start-page: 705
  year: 2017
  end-page: 707
  ident: CR37
  article-title: Increase in prostate cancer distant metastases at diagnosis in the united states
  publication-title: JAMA Oncol.
– volume: 50
  start-page: 125
  year: 1966
  end-page: 128
  ident: CR68
  article-title: Classification of prostatic carcinomas
  publication-title: Cancer Chemother. Rep.
– volume: 377
  start-page: 338
  year: 2017
  end-page: 351
  ident: CR173
  article-title: Abiraterone for prostate cancer not previously treated with hormone therapy
  publication-title: N. Engl. J. Med.
– volume: 280
  start-page: 969
  year: 1998
  end-page: 974
  ident: CR82
  article-title: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
  publication-title: JAMA
– volume: 17
  start-page: 1499
  year: 1999
  end-page: 1507
  ident: CR85
  article-title: Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer
  publication-title: J. Clin. Oncol.
– volume: 317
  start-page: 1949
  year: 2017
  end-page: 1950
  ident: CR39
  article-title: The US preventive services task force 2017 draft recommendation statement on screening for prostate cancer: an invitation to review and comment
  publication-title: JAMA
– volume: 271
  start-page: 368
  year: 1994
  end-page: 374
  ident: CR197
  article-title: Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer
  publication-title: JAMA
– volume: 59
  start-page: 1352
  year: 2004
  end-page: 1359
  ident: CR144
  article-title: Combined modality treatment in the management of high-risk prostate cancer
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
– volume: 23
  start-page: 8247
  year: 2005
  end-page: 8252
  ident: CR163
  article-title: Management of advanced prostate cancer after first-line chemotherapy
  publication-title: J. Clin. Oncol.
– volume: 4
  start-page: 473
  year: 1983
  end-page: 485
  ident: CR55
  article-title: Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations
  publication-title: Prostate
– volume: 40
  start-page: 244
  year: 2016
  end-page: 252
  ident: CR73
  article-title: The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system
  publication-title: Am. J. Surg. Pathol.
– volume: 377
  start-page: 132
  year: 2017
  end-page: 142
  ident: CR104
  article-title: Follow-up of prostatectomy versus observation for early prostate cancer
  publication-title: N. Engl. J. Med.
– volume: 196
  start-page: 1047
  year: 2016
  end-page: 1052
  ident: CR4
  article-title: Decline in prostate cancer screening by primary care physicians: an analysis of trends in the use of digital rectal examination and prostate specific antigen testing
  publication-title: J. Urol.
– volume: 61
  start-page: 1285
  year: 2005
  end-page: 1290
  ident: CR129
  article-title: Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85–31
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
– volume: 6
  start-page: 841
  year: 2005
  end-page: 850
  ident: CR126
  article-title: Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial
  publication-title: Lancet Oncol.
– volume: 151
  start-page: 1283
  year: 1994
  end-page: 1290
  ident: CR26
  article-title: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men
  publication-title: J. Urol.
– volume: 12
  start-page: 601
  year: 2015
  end-page: 602
  ident: CR196
  article-title: A simplified prostate cancer grading system
  publication-title: Nat. Rev. Urol.
– volume: 42
  start-page: 197
  year: 2015
  end-page: 209
  ident: CR78
  article-title: The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
  publication-title: Eur. J. Nuclear Med. Mol. Imag.
– volume: 94
  start-page: 1071
  year: 2004
  end-page: 1076
  ident: CR52
  article-title: Anatomical studies of the neurovascular bundle and cavernosal nerves
  publication-title: BJU Int.
– volume: 5
  start-page: 267
  year: 1982
  end-page: 275
  ident: CR150
  article-title: New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen
  publication-title: Clin. Invest. Med.
– volume: 85
  start-page: 121
  year: 1965
  end-page: 129
  ident: CR123
  article-title: Linear accelerator supervoltage radiotherapy. VII. Carcinoma of the prostate
  publication-title: Radiology
– volume: 14
  start-page: 26
  year: 2016
  ident: CR5
  article-title: The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA
  publication-title: Nat. Rev. Urol.
– volume: 367
  start-page: 203
  year: 2012
  end-page: 213
  ident: CR103
  article-title: Radical prostatectomy versus observation for localized prostate cancer
  publication-title: N. Engl. J. Med.
– volume: 18
  start-page: 111
  year: 1991
  end-page: 122
  ident: CR149
  article-title: Use of cyproterone acetate in prostate cancer
  publication-title: Urol. Clin. North Am.
– volume: 128
  start-page: 492
  year: 1982
  end-page: 497
  ident: CR53
  article-title: Impotence following radical prostatectomy: insight into etiology and prevention
  publication-title: J. Urol.
– volume: 100
  start-page: 1144
  year: 2008
  end-page: 1154
  ident: CR100
  article-title: Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial
  publication-title: J. Natl Cancer Inst.
– volume: 277
  start-page: 1445
  year: 1997
  end-page: 1451
  ident: CR83
  article-title: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update
  publication-title: JAMA
– volume: 6
  start-page: 101
  year: 2004
  end-page: 113
  ident: CR76
  article-title: Imaging in the diagnosis and management of prostate cancer
  publication-title: Rev. Urol.
– volume: 324
  start-page: 1156
  year: 1991
  end-page: 1161
  ident: CR25
  article-title: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
  publication-title: N. Engl. J. Med.
– volume: 349
  start-page: 215
  year: 2003
  end-page: 224
  ident: CR44
  article-title: The influence of finasteride on the development of prostate cancer
  publication-title: N. Engl. J. Med.
– volume: 301
  start-page: 39
  year: 2009
  end-page: 51
  ident: CR48
  article-title: Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
  publication-title: JAMA
– volume: 82
  start-page: 73
  year: 2016
  end-page: 76
  ident: CR38
  article-title: Prostate cancer screening practices and diagnoses in patients age 50 and older, Southeastern Michigan, pre/post 2012
  publication-title: Prev. Med.
– volume: 388
  start-page: 1057
  year: 2016
  end-page: 1066
  ident: CR121
  article-title: Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study
  publication-title: Lancet
– volume: 2
  start-page: 35
  year: 1981
  end-page: 49
  ident: CR50
  article-title: The zonal anatomy of the prostate
  publication-title: Prostate
– volume: 17
  start-page: 292
  year: 2004
  end-page: 306
  ident: CR70
  article-title: Gleason grading and prognostic factors in carcinoma of the prostate
  publication-title: Mod. Pathol.
– volume: 23
  start-page: 4146
  year: 2005
  end-page: 4151
  ident: CR115
  article-title: Achieving optimal outcomes after radical prostatectomy
  publication-title: J. Clin. Oncol.
– volume: 165
  start-page: 1964
  year: 2001
  end-page: 1966
  ident: CR119
  article-title: Laparoscopic radical prostatectomy with a remote controlled robot
  publication-title: J. Urol.
– volume: 319
  start-page: 1901
  year: 2018
  end-page: 1913
  ident: CR40
  article-title: Screening for prostate cancer: US Preventive Services TaskForce recommendation statement
  publication-title: JAMA
– volume: 5
  start-page: 101
  year: 2004
  end-page: 106
  ident: CR107
  article-title: Active surveillance: towards a new paradigm in the management of early prostate cancer
  publication-title: Lancet Oncol.
– volume: 18
  start-page: 611
  year: 2004
  end-page: 619
  ident: CR120
  article-title: Vattikuti Institute prostatectomy: a technique of robotic radical prostatectomy: experience in more than 1000 cases
  publication-title: J. Endourol.
– volume: 281
  start-page: 1591
  year: 1999
  end-page: 1597
  ident: CR18
  article-title: Natural history of progression after PSA elevation following radical prostatectomy
  publication-title: JAMA
– volume: 368
  start-page: 138
  year: 2013
  end-page: 148
  ident: CR184
  article-title: Abiraterone in metastatic prostate cancer without previous chemotherapy
  publication-title: N. Engl. J. Med.
– volume: 378
  start-page: 1767
  year: 2018
  end-page: 1777
  ident: CR67
  article-title: MRI-targeted or standard biopsy for prostate-cancer diagnosis
  publication-title: N. Engl. J. Med.
– volume: 5
  start-page: 912
  year: 1987
  end-page: 917
  ident: CR148
  article-title: Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer
  publication-title: J. Clin. Oncol.
– volume: 267
  start-page: 2215
  year: 1992
  end-page: 2220
  ident: CR21
  article-title: Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease
  publication-title: JAMA
– volume: 14
  start-page: 149
  year: 2013
  end-page: 158
  ident: CR170
  article-title: Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial
  publication-title: Lancet Oncol.
– volume: 114
  start-page: 384
  year: 2014
  end-page: 388
  ident: CR66
  article-title: Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy?
  publication-title: BJU Int.
– volume: 12
  start-page: 1665
  year: 2006
  end-page: 1671
  ident: CR178
  article-title: Mechanisms underlying the development of androgen-independent prostate cancer
  publication-title: Clin. Cancer Res.
– volume: 367
  start-page: 895
  year: 2012
  end-page: 903
  ident: CR155
  article-title: Intermittent androgen suppression for rising PSA level after radiotherapy
  publication-title: N. Engl. J. Med.
– volume: 24
  start-page: 492
  year: 2006
  ident: 60_CR63
  publication-title: Urol. Oncol.
  doi: 10.1016/j.urolonc.2006.03.003
– volume: 163
  start-page: 1643
  year: 2000
  ident: 60_CR117
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(05)67512-X
– volume: 4
  issue: Suppl. 1
  year: 2009
  ident: 60_CR12
  publication-title: Infect. Agent Cancer.
– volume: 10
  start-page: 440
  year: 2004
  ident: 60_CR175
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-1146-03
– volume: 281
  start-page: 1591
  year: 1999
  ident: 60_CR18
  publication-title: JAMA
  doi: 10.1001/jama.281.17.1591
– volume: 17
  start-page: 337
  year: 1990
  ident: 60_CR13
  publication-title: Prostate
  doi: 10.1002/pros.2990170409
– volume: 128
  start-page: 492
  year: 1982
  ident: 60_CR53
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(17)53012-8
– volume: 313
  start-page: 390
  year: 2015
  ident: 60_CR61
  publication-title: JAMA
  doi: 10.1001/jama.2014.17942
– volume: 365
  start-page: 107
  year: 2011
  ident: 60_CR128
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1012348
– volume: 317
  start-page: 1949
  year: 2017
  ident: 60_CR39
  publication-title: JAMA
  doi: 10.1001/jama.2017.4413
– volume: 27
  start-page: 1502
  year: 2009
  ident: 60_CR47
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2008.16.9599
– volume: 151
  start-page: 54
  year: 1994
  ident: 60_CR195
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(17)34871-1
– volume: 5
  start-page: 912
  year: 1987
  ident: 60_CR148
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.1987.5.6.912
– volume: 76
  start-page: 1245
  year: 2010
  ident: 60_CR193
  publication-title: Urology
  doi: 10.1016/j.urology.2010.01.027
– volume: 5
  start-page: 101
  year: 2004
  ident: 60_CR107
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(04)01384-1
– volume: 168
  start-page: 914
  year: 2002
  ident: 60_CR111
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(05)64542-9
– volume: 16
  start-page: 152
  year: 2015
  ident: 60_CR185
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(14)71205-7
– volume: 30
  start-page: 327
  year: 2009
  ident: 60_CR92
  publication-title: J. Magnet. Resonance Imag.
  doi: 10.1002/jmri.21824
– volume: 384
  start-page: 2027
  year: 2014
  ident: 60_CR42
  publication-title: Lancet
  doi: 10.1016/S0140-6736(14)60525-0
– volume: 319
  start-page: 1901
  year: 2018
  ident: 60_CR40
  publication-title: JAMA
  doi: 10.1001/jama.2018.3710
– volume: 377
  start-page: 132
  year: 2017
  ident: 60_CR104
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1615869
– volume: 25
  start-page: 146
  year: 2007
  ident: 60_CR93
  publication-title: J. Magnet. Resonance Imag.
  doi: 10.1002/jmri.20793
– volume: 376
  start-page: 1147
  year: 2010
  ident: 60_CR169
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)61389-X
– volume: 14
  start-page: 2763
  year: 2008
  ident: 60_CR168
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-07-0944
– volume: 26
  start-page: 2497
  year: 2008
  ident: 60_CR127
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2007.14.9021
– volume: 68
  start-page: 1037
  year: 2006
  ident: 60_CR64
  publication-title: Urology
  doi: 10.1016/j.urology.2006.05.033
– volume: 50
  start-page: 1243
  year: 2001
  ident: 60_CR132
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/S0360-3016(01)01579-6
– volume: 317
  start-page: 909
  year: 1987
  ident: 60_CR20
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM198710083171501
– volume: 12
  start-page: 1665
  year: 2006
  ident: 60_CR178
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-06-0067
– volume: 151
  start-page: 1283
  year: 1994
  ident: 60_CR26
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(17)35233-3
– volume: 367
  start-page: 895
  year: 2012
  ident: 60_CR155
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1201546
– volume: 14
  start-page: 149
  year: 2013
  ident: 60_CR170
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(12)70560-0
– volume: 105
  start-page: 1526
  year: 2010
  ident: 60_CR81
  publication-title: BJU Int.
  doi: 10.1111/j.1464-410X.2009.09070.x
– volume: 65
  start-page: 5
  year: 2015
  ident: 60_CR1
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21254
– volume: 367
  start-page: 203
  year: 2012
  ident: 60_CR103
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1113162
– volume: 43
  start-page: 209
  year: 1941
  ident: 60_CR147
  publication-title: Arch. Surg.
  doi: 10.1001/archsurg.1941.01210140043004
– volume: 136
  start-page: E359
  year: 2015
  ident: 60_CR2
  publication-title: Int. J. Cancer.
  doi: 10.1002/ijc.29210
– volume: 389
  start-page: 815
  year: 2017
  ident: 60_CR96
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)32401-1
– volume: 142
  start-page: 66
  year: 1989
  ident: 60_CR58
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(17)38663-9
– volume: 324
  start-page: 1156
  year: 1991
  ident: 60_CR25
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM199104253241702
– volume: 360
  start-page: 1310
  year: 2009
  ident: 60_CR31
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa0810696
– volume: 368
  start-page: 1314
  year: 2013
  ident: 60_CR156
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1212299
– volume: 173
  start-page: 1938
  year: 2005
  ident: 60_CR87
  publication-title: J. Urol.
  doi: 10.1097/01.ju.0000158155.33890.e7
– volume: 64
  start-page: 106
  year: 2013
  ident: 60_CR77
  publication-title: Eur. Urol.
  doi: 10.1016/j.eururo.2013.04.019
– volume: 364
  start-page: 1995
  year: 2011
  ident: 60_CR198
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1014618
– ident: 60_CR112
– volume: 291
  start-page: 2713
  year: 2004
  ident: 60_CR17
  publication-title: JAMA
  doi: 10.1001/jama.291.22.2713
– volume: 60
  start-page: 75
  year: 2012
  ident: 60_CR71
  publication-title: Histopathology
  doi: 10.1111/j.1365-2559.2011.04003.x
– volume: 360
  start-page: 1320
  year: 2009
  ident: 60_CR32
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa0810084
– volume: 69
  start-page: 2305
  year: 2009
  ident: 60_CR180
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-08-3795
– volume: 11
  start-page: 375
  year: 2013
  ident: 60_CR157
  publication-title: Clin. Genitourin. Cancer
  doi: 10.1016/j.clgc.2013.05.004
– volume: 95
  start-page: 868
  year: 2003
  ident: 60_CR30
  publication-title: J. Natl Cancer Inst.
  doi: 10.1093/jnci/95.12.868
– volume: 27
  start-page: 2924
  year: 2009
  ident: 60_CR137
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2008.18.9563
– volume: 371
  start-page: 424
  year: 2014
  ident: 60_CR181
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1405095
– volume: 94
  start-page: 1071
  year: 2004
  ident: 60_CR52
  publication-title: BJU Int.
  doi: 10.1111/j.1464-410X.2004.05106.x
– volume: 17
  start-page: 159
  year: 1979
  ident: 60_CR19
  publication-title: Invest. Urol.
– volume: 165
  start-page: 1964
  year: 2001
  ident: 60_CR119
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(05)66251-9
– volume: 82
  start-page: 408
  year: 1998
  ident: 60_CR51
  publication-title: Br. J. Urol.
  doi: 10.1046/j.1464-410X.1998.00749.x
– volume: 159
  start-page: 471
  year: 1998
  ident: 60_CR59
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(01)63951-X
– volume: 96
  start-page: 879
  year: 2004
  ident: 60_CR189
  publication-title: J. Natl Cancer Inst.
  doi: 10.1093/jnci/djh141
– volume: 14
  start-page: 26
  year: 2016
  ident: 60_CR5
  publication-title: Nat. Rev. Urol.
  doi: 10.1038/nrurol.2016.251
– volume: 306
  start-page: 1549
  year: 2011
  ident: 60_CR49
  publication-title: JAMA
  doi: 10.1001/jama.2011.1437
– volume: 147
  start-page: 246A
  year: 1992
  ident: 60_CR116
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(17)37206-3
– volume: 143
  start-page: 1146
  year: 1990
  ident: 60_CR24
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(17)40211-4
– volume: 35
  start-page: e235
  year: 2016
  ident: 60_CR109
  publication-title: Am. Soc. Clin. Oncol.
  doi: 10.1200/EDBK_159244
– volume: 85
  start-page: 121
  year: 1965
  ident: 60_CR123
  publication-title: Radiology
  doi: 10.1148/85.1.121
– volume: 368
  start-page: 138
  year: 2013
  ident: 60_CR184
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1209096
– volume: 280
  start-page: 969
  year: 1998
  ident: 60_CR82
  publication-title: JAMA
  doi: 10.1001/jama.280.11.969
– volume: 102
  start-page: 10
  year: 2008
  ident: 60_CR110
  publication-title: BJU Int.
  doi: 10.1111/j.1464-410X.2008.07585.x
– volume: 172
  start-page: 1267
  year: 2012
  ident: 60_CR6
  publication-title: Arch. Intern. Med.
  doi: 10.1001/archinternmed.2012.2768
– volume: 35
  start-page: LBA3
  year: 2017
  ident: 60_CR174
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2017.35.15_suppl.LBA3
– volume: 17
  start-page: 727
  year: 2016
  ident: 60_CR152
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(16)00107-8
– year: 2017
  ident: 60_CR75
  publication-title: J. Urol.
  doi: 10.1016/j.juro.2017.11.095
– volume: 72
  start-page: 326
  year: 2017
  ident: 60_CR9
  publication-title: Eur. Urol.
  doi: 10.1016/j.eururo.2017.05.011
– volume: 375
  start-page: 1415
  year: 2016
  ident: 60_CR102
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1606220
– volume: 14
  start-page: S12
  year: 2015
  ident: 60_CR143
  publication-title: Brachytherapy
  doi: 10.1016/j.brachy.2015.02.200
– volume: 373
  start-page: 737
  year: 2015
  ident: 60_CR171
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1503747
– volume: 293
  start-page: 2095
  year: 2005
  ident: 60_CR16
  publication-title: JAMA
  doi: 10.1001/jama.293.17.2095
– volume: 301
  start-page: 39
  year: 2009
  ident: 60_CR48
  publication-title: JAMA
  doi: 10.1001/jama.2008.864
– volume: 371
  start-page: 1028
  year: 2014
  ident: 60_CR179
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1315815
– volume: 162
  start-page: 331
  year: 1987
  ident: 60_CR90
  publication-title: Radiology
  doi: 10.1148/radiology.162.2.3797645
– volume: 34
  start-page: 2098
  year: 2016
  ident: 60_CR199
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2015.64.9285
– volume: 190
  start-page: 419
  year: 2013
  ident: 60_CR22
  publication-title: J. Urol.
  doi: 10.1016/j.juro.2013.04.119
– volume: 2
  start-page: 35
  year: 1981
  ident: 60_CR50
  publication-title: Prostate
  doi: 10.1002/pros.2990020105
– volume: 110
  start-page: 812
  year: 2012
  ident: 60_CR65
  publication-title: BJU Int.
  doi: 10.1111/j.1464-410X.2012.10933.x
– volume: 82
  start-page: 73
  year: 2016
  ident: 60_CR38
  publication-title: Prev. Med.
  doi: 10.1016/j.ypmed.2015.11.017
– volume: 277
  start-page: 1445
  year: 1997
  ident: 60_CR83
  publication-title: JAMA
  doi: 10.1001/jama.1997.03540420041027
– volume: 117
  start-page: 5039
  year: 2011
  ident: 60_CR88
  publication-title: Cancer
  doi: 10.1002/cncr.26169
– volume: 37
  start-page: 616
  year: 2014
  ident: 60_CR136
  publication-title: Am. J. Clin. Oncol.
  doi: 10.1097/COC.0b013e31827e4eb9
– volume: 321
  start-page: 419
  year: 1989
  ident: 60_CR151
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM198908173210702
– volume: 13
  start-page: 983
  year: 2012
  ident: 60_CR186
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(12)70379-0
– volume: 12
  start-page: 891
  year: 2011
  ident: 60_CR101
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(11)70162-0
– volume: 43
  start-page: 209
  year: 1941
  ident: 60_CR146
  publication-title: Arch. Surg.
  doi: 10.1001/archsurg.1941.01210140043004
– volume: 273
  start-page: 548
  year: 1995
  ident: 60_CR7
  publication-title: JAMA
  doi: 10.1001/jama.1995.03520310046028
– volume: 296
  start-page: 2329
  year: 2006
  ident: 60_CR140
  publication-title: JAMA
  doi: 10.1001/jama.296.19.2329
– volume: 196
  start-page: 1047
  year: 2016
  ident: 60_CR4
  publication-title: J. Urol.
  doi: 10.1016/j.juro.2016.03.171
– volume: 71
  start-page: 705
  issue: 5
  year: 2017
  ident: 60_CR89
  publication-title: European Urology
  doi: 10.1016/j.eururo.2016.08.065
– volume: 23
  start-page: 4146
  year: 2005
  ident: 60_CR115
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2005.12.922
– volume: 181
  start-page: 731
  year: 2009
  ident: 60_CR122
  publication-title: J. Urol.
  doi: 10.1016/j.juro.2008.10.019
– volume: 198
  start-page: 832
  year: 2017
  ident: 60_CR97
  publication-title: J. Urol.
  doi: 10.1016/j.juro.2017.04.101
– volume: 17
  start-page: 1047
  year: 2016
  ident: 60_CR145
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(16)30102-4
– volume: 90
  start-page: 766
  year: 1998
  ident: 60_CR84
  publication-title: J. Natl Cancer Inst.
  doi: 10.1093/jnci/90.10.766
– volume: 377
  start-page: 813
  year: 2011
  ident: 60_CR190
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)62344-6
– volume: 319
  start-page: 883
  year: 2018
  ident: 60_CR43
  publication-title: JAMA
  doi: 10.1001/jama.2018.0154
– volume: 177
  start-page: 1632
  year: 2007
  ident: 60_CR114
  publication-title: J. Urol.
  doi: 10.1016/j.juro.2007.01.012
– volume: 26
  start-page: 585
  year: 2008
  ident: 60_CR130
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2007.13.9881
– volume: 193
  start-page: 1519
  year: 2015
  ident: 60_CR35
  publication-title: J. Urol.
  doi: 10.1016/j.juro.2014.11.096
– volume: 380
  start-page: 2018
  year: 2012
  ident: 60_CR142
  publication-title: Lancet
  doi: 10.1016/S0140-6736(12)61253-7
– volume: 369
  start-page: 213
  year: 2013
  ident: 60_CR187
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1213755
– volume: 3
  start-page: 705
  year: 2017
  ident: 60_CR37
  publication-title: JAMA Oncol.
  doi: 10.1001/jamaoncol.2016.5465
– volume: 98
  start-page: 715
  year: 2006
  ident: 60_CR86
  publication-title: J. Natl Cancer Inst.
  doi: 10.1093/jnci/djj190
– volume: 4
  start-page: 473
  year: 1983
  ident: 60_CR55
  publication-title: Prostate
  doi: 10.1002/pros.2990040506
– ident: 60_CR69
– volume: 66
  start-page: 243
  year: 2014
  ident: 60_CR138
  publication-title: Eur. Urol.
  doi: 10.1016/j.eururo.2014.03.011
– volume: 373
  start-page: 301
  year: 2009
  ident: 60_CR133
  publication-title: Lancet
  doi: 10.1016/S0140-6736(08)61815-2
– volume: 367
  start-page: 1187
  year: 2012
  ident: 60_CR183
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1207506
– volume: 14
  start-page: 509
  year: 2016
  ident: 60_CR29
  publication-title: J. Natl Compr. Cancer Netw.
  doi: 10.6004/jnccn.2016.0060
– volume: 351
  start-page: 1513
  year: 2004
  ident: 60_CR166
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa041318
– volume: 181
  start-page: 956
  year: 2009
  ident: 60_CR139
  publication-title: J. Urol.
  doi: 10.1016/j.juro.2008.11.032
– volume: 71
  start-page: 630
  year: 2017
  ident: 60_CR162
  publication-title: Eur. Urol.
  doi: 10.1016/j.eururo.2016.08.002
– volume: 18
  start-page: 611
  year: 2004
  ident: 60_CR120
  publication-title: J. Endourol.
  doi: 10.1089/end.2004.18.611
– volume: 179
  start-page: 1354
  year: 2008
  ident: 60_CR80
  publication-title: J. Urol.
  doi: 10.1016/j.juro.2007.11.061
– volume: 71
  start-page: 3975
  year: 1993
  ident: 60_CR164
  publication-title: Cancer
  doi: 10.1002/1097-0142(19930615)71:12<3975::AID-CNCR2820711229>3.0.CO;2-D
– volume: 17
  start-page: 1499
  year: 1999
  ident: 60_CR85
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.1999.17.5.1499
– volume: 368
  start-page: 436
  year: 2013
  ident: 60_CR194
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1209978
– volume: 22
  start-page: 369
  year: 2016
  ident: 60_CR176
  publication-title: Nat. Med.
  doi: 10.1038/nm.4053
– volume: 5
  start-page: 201
  year: 2009
  ident: 60_CR118
  publication-title: Int. J. Biomed. Sci.
  doi: 10.59566/IJBS.2009.5201
– volume: 60
  start-page: 70
  year: 2010
  ident: 60_CR23
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.20066
– volume: 246
  start-page: 693
  year: 1945
  ident: 60_CR113
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(45)91030-0
– volume: 280
  start-page: 975
  year: 1998
  ident: 60_CR15
  publication-title: JAMA
  doi: 10.1001/jama.280.11.975
– year: 2018
  ident: 60_CR46
  publication-title: Natl Cancer Inst.
  doi: 10.1093/jnci/djy035
– volume: 59
  start-page: 1352
  year: 2004
  ident: 60_CR144
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/j.ijrobp.2004.01.023
– volume: 65
  start-page: 289
  year: 2014
  ident: 60_CR165
  publication-title: Eur. Urol.
  doi: 10.1016/j.eururo.2013.08.008
– volume: 369
  start-page: 603
  year: 2013
  ident: 60_CR45
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1215932
– volume: 8
  start-page: 312
  year: 2011
  ident: 60_CR106
  publication-title: Nat. Rev. Urol.
  doi: 10.1038/nrurol.2011.50
– volume: 6
  start-page: 841
  year: 2005
  ident: 60_CR126
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(05)70348-X
– volume: 341
  start-page: 1781
  year: 1999
  ident: 60_CR153
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM199912093412401
– volume: 366
  start-page: 572
  year: 2005
  ident: 60_CR141
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)67101-2
– volume: 10
  start-page: 690
  year: 2013
  ident: 60_CR62
  publication-title: Nat. Rev. Urol.
  doi: 10.1038/nrurol.2013.195
– volume: 50
  start-page: 125
  year: 1966
  ident: 60_CR68
  publication-title: Cancer Chemother. Rep.
– volume: 387
  start-page: 1163
  year: 2016
  ident: 60_CR172
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(15)01037-5
– volume: 64
  start-page: 159
  year: 2013
  ident: 60_CR160
  publication-title: Eur. Urol.
  doi: 10.1016/j.eururo.2012.04.035
– volume: 23
  start-page: 8247
  year: 2005
  ident: 60_CR163
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2005.03.1435
– volume: 15
  start-page: 189
  year: 2012
  ident: 60_CR3
  publication-title: Prostate Cancer Prostat. Dis.
  doi: 10.1038/pcan.2011.59
– volume: 56
  start-page: 899
  year: 2000
  ident: 60_CR192
  publication-title: Urology
  doi: 10.1016/S0090-4295(00)00858-X
– volume: 378
  start-page: 2104
  year: 2011
  ident: 60_CR134
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)61095-7
– volume: 100
  start-page: 1144
  year: 2008
  ident: 60_CR100
  publication-title: J. Natl Cancer Inst.
  doi: 10.1093/jnci/djn255
– volume: 337
  start-page: 295
  year: 1997
  ident: 60_CR131
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM199707313370502
– volume: 35
  start-page: 663.e1
  year: 2017
  ident: 60_CR8
  publication-title: Urol. Oncol.
  doi: 10.1016/j.urolonc.2017.06.059
– volume: 388
  start-page: 1057
  year: 2016
  ident: 60_CR121
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)30592-X
– volume: 7
  start-page: 472
  year: 2006
  ident: 60_CR154
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(06)70700-8
– volume: 66
  start-page: 489
  year: 2014
  ident: 60_CR14
  publication-title: Eur. Urol.
  doi: 10.1016/j.eururo.2014.01.003
– volume: 157
  start-page: 120
  year: 2012
  ident: 60_CR33
  publication-title: Ann. Intern. Med.
  doi: 10.7326/0003-4819-157-2-201207170-00459
– volume: 16
  start-page: 451
  year: 2002
  ident: 60_CR91
  publication-title: J. Magnet. Resonance Imag.
  doi: 10.1002/jmri.10172
– volume: 33
  start-page: 272
  year: 2015
  ident: 60_CR108
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2014.55.1192
– volume: 36
  start-page: 1002
  year: 1998
  ident: 60_CR191
  publication-title: Med. Care.
  doi: 10.1097/00005650-199807000-00007
– volume: 55
  start-page: 668
  year: 2015
  ident: 60_CR79
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.115.154153
– volume: 351
  start-page: 1502
  year: 2004
  ident: 60_CR167
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa040720
– volume: 19
  start-page: 395
  year: 2016
  ident: 60_CR36
  publication-title: Prostate Cancer Prostatic Dis.
  doi: 10.1038/pcan.2016.30
– volume: 42
  start-page: 197
  year: 2015
  ident: 60_CR78
  publication-title: Eur. J. Nuclear Med. Mol. Imag.
  doi: 10.1007/s00259-014-2949-6
– volume: 6
  start-page: 101
  year: 2004
  ident: 60_CR76
  publication-title: Rev. Urol.
– volume: 17
  start-page: 292
  year: 2004
  ident: 60_CR70
  publication-title: Mod. Pathol.
  doi: 10.1038/modpathol.3800054
– volume: 173
  start-page: 534
  year: 1990
  ident: 60_CR177
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/S0006-291X(05)80067-1
– volume: 60
  start-page: 526
  year: 1987
  ident: 60_CR54
  publication-title: Cancer
  doi: 10.1002/1097-0142(19870801)60:3+<526::AID-CNCR2820601515>3.0.CO;2-9
– volume: 88
  start-page: 226
  year: 2001
  ident: 60_CR74
  publication-title: BJU Int.
  doi: 10.1046/j.1464-410x.2001.02275.x
– volume: 299
  start-page: 289
  year: 2008
  ident: 60_CR125
  publication-title: JAMA
  doi: 10.1001/jama.299.3.289
– volume: 18
  start-page: 111
  year: 1991
  ident: 60_CR149
  publication-title: Urol. Clin. North Am.
  doi: 10.1016/S0094-0143(21)01398-7
– volume: 271
  start-page: 368
  year: 1994
  ident: 60_CR197
  publication-title: JAMA
  doi: 10.1001/jama.1994.03510290050036
– volume: 5
  start-page: 267
  year: 1982
  ident: 60_CR150
  publication-title: Clin. Invest. Med.
– volume: 26
  start-page: 1606
  year: 2016
  ident: 60_CR95
  publication-title: Eur. Radiol.
  doi: 10.1007/s00330-015-4015-6
– volume: 92
  start-page: 613
  year: 2000
  ident: 60_CR98
  publication-title: J. Natl Cancer Inst.
  doi: 10.1093/jnci/92.8.613
– volume: 12
  start-page: 601
  year: 2015
  ident: 60_CR196
  publication-title: Nat. Rev. Urol.
  doi: 10.1038/nrurol.2015.212
– volume: 180
  start-page: 548
  year: 2008
  ident: 60_CR72
  publication-title: J. Urol.
  doi: 10.1016/j.juro.2008.04.018
– volume: 40
  start-page: 244
  year: 2016
  ident: 60_CR73
  publication-title: Am. J. Surg. Pathol.
  doi: 10.1097/PAS.0000000000000530
– volume: 363
  start-page: 411
  year: 2010
  ident: 60_CR200
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1001294
– volume: 22
  start-page: 746
  year: 2012
  ident: 60_CR94
  publication-title: Eur. Radiol.
  doi: 10.1007/s00330-011-2377-y
– volume: 115
  start-page: 3
  issue: Suppl. 5
  year: 2015
  ident: 60_CR159
  publication-title: BJU Int.
  doi: 10.1111/bju.12964
– volume: 94
  start-page: 1458
  year: 2002
  ident: 60_CR188
  publication-title: J. Natl Cancer Inst.
  doi: 10.1093/jnci/94.19.1458
– volume: 349
  start-page: 215
  year: 2003
  ident: 60_CR44
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa030660
– volume: 169
  start-page: 125
  year: 2003
  ident: 60_CR60
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(05)64051-7
– volume: 61
  start-page: 1285
  year: 2005
  ident: 60_CR129
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/j.ijrobp.2004.08.047
– volume: 378
  start-page: 1767
  year: 2018
  ident: 60_CR67
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1801993
– volume: 377
  start-page: 338
  year: 2017
  ident: 60_CR173
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1702900
– ident: 60_CR10
– volume: 12
  start-page: 229
  year: 2002
  ident: 60_CR135
  publication-title: Semin. Radiat. Oncol.
  doi: 10.1053/srao.2002.00000
– volume: 267
  start-page: 2215
  year: 1992
  ident: 60_CR21
  publication-title: JAMA
  doi: 10.1001/jama.1992.03480160073037
– volume: 34
  start-page: 168
  year: 1922
  ident: 60_CR56
  publication-title: Surg. Gynecol. Obstet.
– volume-title: Young’s Practice of Urology
  year: 1926
  ident: 60_CR57
– volume: 114
  start-page: 384
  year: 2014
  ident: 60_CR66
  publication-title: BJU Int.
  doi: 10.1111/bju.12536
– volume: 314
  start-page: 2054
  year: 2015
  ident: 60_CR34
  publication-title: JAMA
  doi: 10.1001/jama.2015.14905
– volume: 350
  start-page: 2239
  year: 2004
  ident: 60_CR27
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa031918
– volume: 62
  start-page: 745
  year: 2012
  ident: 60_CR41
  publication-title: Eur. Urol.
  doi: 10.1016/j.eururo.2012.05.068
– volume: 167
  start-page: 1664
  year: 2002
  ident: 60_CR105
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(05)65174-9
– volume: 93
  start-page: 975
  year: 2004
  ident: 60_CR158
  publication-title: BJU Int.
  doi: 10.1111/j.1464-410X.2004.04763.x
– volume: 6
  start-page: 87
  year: 2009
  ident: 60_CR11
  publication-title: Nat. Clin. Practice Urol.
  doi: 10.1038/ncpuro1290
– volume: 360
  start-page: 2516
  year: 2009
  ident: 60_CR124
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa0810095
– volume: 95
  start-page: E456
  year: 2010
  ident: 60_CR161
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2010-0902
– volume: 71
  start-page: 618
  year: 2017
  ident: 60_CR28
  publication-title: Eur. Urol.
  doi: 10.1016/j.eururo.2016.08.003
– volume: 17
  start-page: 153
  year: 2016
  ident: 60_CR182
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(15)00518-5
– volume: 63
  start-page: 207
  year: 2004
  ident: 60_CR99
  publication-title: Urology
  doi: 10.1016/S0090-4295(03)00243-7
SSID ssj0066476
Score 2.4792519
SecondaryResourceType review_article
Snippet The field of prostate cancer has been the subject of extensive research that has resulted in important discoveries and shaped our appreciation of this disease...
SourceID proquest
gale
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 627
SubjectTerms 692/308/409
692/699/67/2322
692/699/67/589/466
692/700
Cancer surgery
Care and treatment
Development and progression
Evaluation
Health status indicators
Medicine
Medicine & Public Health
Perspective
Prognosis
Prostate cancer
Urological surgery
Urology
Title Landmarks in prostate cancer
URI https://link.springer.com/article/10.1038/s41585-018-0060-7
https://www.ncbi.nlm.nih.gov/pubmed/30065357
https://www.proquest.com/docview/2116055203
https://www.proquest.com/docview/2081543940
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dSyMxcPAU5F7E886zWr09EA6U4HaTbNIn8Y4WERURhb6FNJuF43Rb2_r_nclmVyucz5nsZiaZj2S-AA5Rqdme8ylTeeGZ8P0e0z1eMiudz4XnvSI8DVxd5-f34mIkR_HBbR7DKhuZGAR1MXH0Rn6CFxW0vGWW8tPpE6OuUeRdjS00PsEalS6jkC41ai9ceS5CcznUkH0mUJM1Xk2uT-aouDSFrWlGJUmYWtJL76XzG_X0zl8a1NBwEzai_Zic1Rv-BVZ8tQXrV9FD_hW6l7YqHu3s3zz5WyVTyulAazJxtLmzb3A_HNz9OWexAwJzQqUL5qQlkWbHorC-RLrpUmifCV8oJ6iUny51mpWZLbhD08Tllmvr0zHdI0plS74Nq9Wk8juQ5JnT4zLLOc-4UMr2qUZnKhG28Fxa2YG0wd-4WB6culQ8mOCm5trUJDNIMkMkM6oDR-2UaV0b4yPgH0RUU6d3tnxlziSa9ygFFK7gV4AgzsI_OxsTBHD9VKNqCbK7BIkc4ZaHm40zkSPn5vX8dOBnO0wzKcqs8pNnhEH7SFKqcNqB7_WGt4jxUMVXIh7HzQl4_fh_sd79eCl78DmjIxiCA7uwupg9-300chbjg3CSD2Dt9-D65vYFHJ_zAg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dTxsxDLdYkdheprHPbgUOadOkTRHXfFzSh2kCBirQVtMEEm8hzeWkCXbt2qKJf4q_cfZ9FIoEbzzHl0scxz8njm2Ajwhqru1DzHSSBiZDp81MW2TMKR8SGUQ7La4G-oOkeyIPT9XpElzXsTD0rLLWiYWiTkee7si38KCClrfisfg-_suoahR5V-sSGqVYHIWrf3hkm347-IHr-4nz_b3j3S6rqgowL3U8Y145UhNuKFMXMhyLyaQJXIZUe0np8UxmYp5xlwqPcO8TJ4wL8ZBs80y7TGC_T2BZCjzKNGB5Z2_w81et-5NEFuXsEJM7TCJ21n5UYbamCJWGHsoZRklQmF5Awrt4cAsQ73hoC-DbfwHPK4s12i5FbBWWQv4SVvqVT_4VtHouT_-4yfk0-p1HY4oiQfs18iROk9dw8ijceQONfJSHdxAl3JthxhMhuJBauw5lBY0V0qZBKKeaENfzt75KSE51MS5s4RgXxpYss8gySyyzuglf5p-My2wcDxFvEFNtGVA638l2W-GBAvWOxhF8LihoL-OfvatCEnD8lBVrgbK1QIl70C821wtnKx0wtTcS24TNeTN9Se_a8jC6RBq0yBQFJ8dNeFsu-HxiosgbrHAeX2sJuOn83lm_f3goG_C0e9zv2d7B4OgDPOMkjsXTxBY0ZpPLsIYm1my4Xsl1BGePvZX-A9JaMHA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3ZbhMxcFSKVPGCytnQQBcJhASysutj7TwgVFGilh7igUp5M47XKyFgkyapqv5av44Z71FSib712bNeezyXPRfAG1RqLvMhZTovApNhmDGTiZI55UMug8iK-DRwfJLvn8qvYzVeg6s2F4bCKluZGAV1MfX0Rj7Aiwpa3oqnYlA2YRHf9kafZmeMOkiRp7Vtp1GTyGG4vMDr2-LjwR6e9VvOR1--f95nTYcB5qVOl8wrRyLDTWThQonrMqU0gctQaC-pVJ4pTcpL7grhUfX73AnjQjohO73UrhQ47z24r4XKiMf0uLvs5bmMje1QOw-ZRC3aelSFGSxQaRoKmTOMyqEwvaITb2qGf1TjDV9tVIGjTXjY2K7Jbk1sj2AtVI9h47jxzj-B_pGrij9u_muR_KySGeWToCWbeCKs-VM4vRPcPIP1alqFLUhy7s2k5LkQXEit3ZDqg6YKYYsglFM9SNv9W9-UJqcOGb9tdJELY2uUWUSZJZRZ3YP33Sezui7HbcA7hFRbp5Z2PG13FV4tUAJpXMG7CEFcjX_2rklOwPVTfawVyP4KJHKjXx1uD8420mBhr2m3B6-7YfqSItyqMD1HGLTNFKUppz14Xh94tzERKwgr3MeHlgKuJ__vrl_cvpQd2EAGskcHJ4fb8IATNcYYxT6sL-fn4SXaWsvJq0jUCfy4ay76Cw7-M0A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Landmarks+in+prostate+cancer&rft.jtitle=Nature+reviews.+Urology&rft.au=Sathianathen%2C+Niranjan+J.&rft.au=Konety%2C+Badrinath+R.&rft.au=Crook%2C+Juanita&rft.au=Saad%2C+Fred&rft.date=2018-10-01&rft.issn=1759-4812&rft.eissn=1759-4820&rft.volume=15&rft.issue=10&rft.spage=627&rft.epage=642&rft_id=info:doi/10.1038%2Fs41585-018-0060-7&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s41585_018_0060_7
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1759-4812&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1759-4812&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1759-4812&client=summon